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This study was conceived with the main intention of 
examining the quality of care for patients with dysphagia. 
In order to try and focus on the specific issues of relevance 
to dysphagia, it was decided that it would be best to take 
dysphagia in the context of one diagnostic group. Given the 
reportedly high prevalence of dysphagia affecting patients 
with Parkinson’s disease (PD) and parkinsonism, patients 
were selected for sampling if they were admitted acutely 
to hospital and had a diagnosis of PD. So, when reading 
this report, bear in mind that it was not intended to give 
a comprehensive overview of the care of PD patients, but 
rather to allow an in-depth review of dysphagia recognition 
and care. It also stands that the learning from this report 
should be transferable, and systematic improvements in 
identifying and managing dysphagia should be relevant for 
all diagnoses associated with dysphagia, not just PD.
The other important factor to be aware of is that sampling 
for this study was undertaken prior to the COVID-19 
pandemic, which will almost certainly lead, in the fullness 
of time, to substantial changes in the infrastructure and 
operation of the NHS.
In addition to the clinical and organisational sources of 
information gathered, this study has also included a sample 
of opinions from patients and carers about the dysphagia 
care which they received while in hospital. Patients and carers 
are a valuable source of information, and this brief insight 
into their views serves to confirm that patients and carers 
know much more about their own chronic conditions than 
us as clinicians. This was demonstrated by the comments that 
some perceived that their problems with swallowing were not 
really taken seriously by healthcare staff.
As is so often the case with NCEPOD reports, this study 
highlights the importance of paying attention to some of 
the basics in care, such as good oral hygiene, hydration, 
nutrition, feeding position and availability of specialist 
advice from speech and language therapists, dietitians, 
nutrition team members and housekeeping to ensure that 
the texture of food and liquids is tailored to the individual 
needs of the patient. Having to wait more than 48 hours 
often with prolonged periods ‘nil by mouth’ because 
you are admitted after 5pm on Friday and these essential 
services stop at the weekend should not be the accepted 
norm in our modern healthcare system.
As ever I, and my fellow trustees, are most grateful to 
all the advisors, case reviewers, patients, local reporters, 
clinicians and ambassadors, together with the NCEPOD 
clinical co-ordinators, and staff who have made this report 
possible. I hope that any healthcare staff who see patients 
with dysphagia, from whatever cause, no matter how 
infrequently, will find the recommendations in this report of 








To examine the pathway of care for patients with Parkinson’s 
disease (PD) who were admitted to hospital when unwell, 
and to explore multidisciplinary care and organisational 
factors in the process of identifying, screening, assessing, 
treating and monitoring of their ability to swallow. 
Method
Adult patients aged 16 and over with PD who were 
acutely unwell and admitted to hospital for at least one 
day, between 7th January and 3rd March 2019. From the 
whole group a maximum of four patients per hospital were 
randomly selected for inclusion. The treating clinician was 
asked to complete a questionnaire and case notes were 
requested for peer review.
Key messages 
Five key messages listed here, have been agreed as the 
primary focus for action, based on the report findings and 
recommendations (see pages 9-11 and Appendix 1).
1. Document the swallow status of all patients with
PD at the point of referral to hospital
Since dysphagia can occur at every stage of PD it is 
important to assess and communicate its presence in a 
referral letter. Information relating to dysphagia was not 
available in the referral letter of 20/79 patients who were 
known to have dysphagia at the point of referral.
2. Screen patients with PD for swallowing difficulties
at admission
Patients admitted to hospital may have swallowing 
difficulties, not recorded as ‘dysphagia’. Other indicators 
should be considered, such as the patient’s ability to 
swallow food, fluids or medication, whether they have 
control of saliva or have a history of pneumonia. 
3. Refer patients with PD who have swallowing
difficulties (or who have problems with
communication) to speech and language therapy
Early input, as needed, from speech and language therapy 
(SLT) is fundamental to improving swallowing difficulties 
and communication for many patients with dysphagia. In 
this study referral to SLT was made following a swallowing 
screen on arrival for 51/209 (24.4%) patients and case 
reviewers were of the opinion that a further 36/132 (27.3%) 
patients should have been referred.
4. Notify the specialist PD service (hospital and/
or community) when a patient with PD is
admitted, if there is any indication from the
notes, or following discussion with the patient
or their relatives/carers, that there has been a
deterioration or progression of their clinical state
For any team caring for a patient with PD it is important 
to know if there has been any unexpected change in the 
patient’s clinical status or care plan. While a majority of 
patients in this study were under the care of a PD service 
prior to their admission, there was no evidence of contact 
with their PD service, on admission, documented in 180/316 
(57%) sets of notes.
5. Provide written information at discharge on how
to manage swallowing difficulties
At the point of discharge from hospital any changes in 
care or medication, as well as swallowing status (including 
the ability to take oral medication), nutrition plan or level 
of future risk of dysphagia should be provided to care 
providers as well as the patient and family members.
Executive summary
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These recommendations have been formed by a consensus 
exercise involving all those listed in the acknowledgements. 
Please see Appendix 1 for how the key findings in the report 
support the recommendations. The recommendations have 
been independently edited by medical editors experienced 
in developing recommendations for healthcare audiences to 
act on.
The recommendations highlight areas that are suitable 
for regular local clinical audit and quality improvement 
initiatives by those providing care to this group of patients. 
The result of local clinical audits or quality improvement 
initiatives should be presented at quality or governance 
meetings and action plans to improve care should be shared 
with executive boards. 
Recommendations
Executive boards are ultimately responsible for supporting the implementation of these recommendations. 
Suggested target audiences to action recommendations are listed in italics under each recommendation. The 
primary target audience/audiences are in bold.
The term ‘healthcare professionals’ includes, all specialties and grades who would be involved in the care of this group 
of patients
1 Document the swallow status of all patients with Parkinson’s disease at the point of referral to hospital.
Target audiences: Primary care and community Parkinson’s disease teams
2 Notify the specialist Parkinson’s disease service (hospital and/or community) when a patient with Parkinson’s disease 
is admitted, if there is any indication from the notes, or following discussion with the patient of their relatives/carers, 
that there has been a deterioration or progression of their clinical state.
Target audiences: Healthcare professionals who see patients at admission, clinical and 
medical directors
3 Screen patients with Parkinson’s disease for swallowing difficulties at admission, irrespective of the reason for 




Target audiences: Healthcare professionals who see patients at admission and clinical directors
4 Refer patients with Parkinson’s disease who have swallowing difficulties* (or who have problems with 
communication) to speech and language therapy. 
Target audiences: Healthcare professionals who see patients throughout their admission and 
clinical directors
*See Figure 4.3 in the report for a list of indicators of swallowing difficulties
10
RECOMMENDATIONS
5 Ensure patients are able to take the medication they have been prescribed at, and throughout, their admission. If 
there are concerns about whether or not the patient can swallow safely consider other formulations of medication 
(e.g. liquid rather than a tablet) or ways of administering them. 
Target audiences: Healthcare professionals who see patients at, and throughout, their admission, 
pharmacists, and clinical directors 
NB: Levodopa should be administered within 30 minutes of the prescribed administration time. This is in line with NICE Quality Standard 164. See also 
the Parkinson’s UK medication optimisation consensus statement 
6 Ensure there is a hospital policy for the different ways of administering medication and the review of medications at 
the point of patient discharge. This includes the use of rotigotine patches.
Target audiences: Clinical directors, medical directors, hospital pharmacists, specialist Parkinson’s 
disease teams and quality improvement leads
7 Screen the nutritional status of patients admitted to hospital with Parkinson’s disease and act on the findings.
Target audiences: Clinical directors, dietitians, nutrition team members and healthcare professionals 
who see patients at, and throughout, their admission
NB: All patients admitted to hospital should undergo a nutritional screen using a validated screening tool such as the BAPEN Malnutrition Universal 
Screening Tool (MUST) this in line with NICE Quality Standard 24
8 Involve speech and language therapists, pharmacists, dietitians and nutrition team members in any multidisciplinary 
(MDT) discussion of patients with Parkinson’s disease and swallowing difficulties.  
Target audiences: Clinical directors, speech and language therapists, pharmacists, dietitians and 
nutrition team members






This is in line with the International Dysphagia Diet Standardisation Initiative (IDDSI) 
Target audiences: Medical directors, clinical directors, clinical teams caring for patients with dysphagia. 
This includes speech and language therapists, pharmacists, dietitians, hospital housekeeping and 
catering services, community Parkinson’s disease teams and quality improvement leads
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RECOMMENDATIONS
10 Ensure there is a hospital policy for ‘risk feeding’ which includes the assessment or re-assessment (if already 







Target audiences: Clinical directors, medical directors, speech and language therapists, pharmacists, 
dietitians and nutrition team members and quality improvement leads












A proforma could be used for this discharge summary. 
Target audiences: Clinical directors, healthcare professionals who see patients throughout their 
admission, quality improvement leads
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Dysphagia is a difficulty in moving food from the mouth 
to the stomach. Well established risk factors for dysphagia 
include advanced age, head and neck cancer, pulmonary 
disease and neurological disease, such as Parkinson’s 
disease (PD). PD is a neurodegenerative disease which 
is increasingly prevalent, and also more common with 
increasing age.1
Estimates of the prevalence of dysphagia in PD vary across 
the literature.2 Reasons for this include patients being 
unaware of their dysphagia, and so not seeking medical 
advice, as well as dysphagia not being recognised or 
documented by healthcare professionals. 
Lack of recognition of dysphagia can lead to serious 
complications. Attempting to take food or drink can 
result in choking or aspiration pneumonia.3 Furthermore, 
patients with dysphagia may be drooling saliva, indicating 
their lack of ability to swallow safely. Assessment of these 
indicators is important, as the inability to swallow can lead 
to dehydration, malnutrition and weight loss.4,5
Patients with PD have a high rate of admission to hospital,6 
and the most common reason for this is pneumonia. As 
dysphagia is an independent predictor of poor outcome in 
acute care,7 is common in PD and can occur at any stage 
of PD, screening for it at the point of admission to hospital 
would provide an opportunity for earlier intervention. 
In addition to eating and drinking, difficulty swallowing 
can also lead to problems taking oral medication. 
Timely administration of medications for PD helps with 
symptom control, as outlined in the Parkinson’s disease 
UK Medicines Optimisation Consensus Statement.8 The 
NICE Quality Standard for Parkinson’s disease (QS 164) 
also highlights that missed doses of levodopa can lead to 
worsening symptoms and serious complications, leading 
to a negative impact on quality of life and prolonged 
hospital stay.9
There are a number of national guidelines written for the 
care of patients with PD, in addition to NICE QS 164. NICE 
Guideline 7110 states that patients with PD should have 
a PD nurse specialist as a point of contact with specialist 
services to facilitate continuity of care, information sharing, 
advice and support. NICE Guideline 7110 and NICE QS 1649 
state that patients with PD should be referred to speech 
and language therapy if problems are identified with 
communication, swallowing or saliva control. Speech and 
language therapists can provide effective assessment, care 
and advice for patients with dysphagia.11
The NICE Quality Standard on nutrition support in adults 
(QS24) also recommends that all patients should be screened 
for the presence (or risk) of malnutrition on admission.12 
Screening should be repeated weekly for inpatients. A 
validated screening tool, such as the Malnutrition Universal 
Screening Tool (MUST) can aid with this.13
Discharge planning should start as early as possible during 
an admission. For people with PD, plans for discharge should 
be co-ordinated across the different groups of professionals 
who are involved in their care during the hospital admission 
and their ongoing care in the community. As well as speech 
and language therapists and the specialist PD team, this 
also includes dietitians, pharmacists, physiotherapists, 
occupational therapists, and the patient’s family where 
appropriate. Any change in PD medication and/or 
specific dietary modifications while in hospital should be 
communicated to the patient’s GP or specialist PD team.9
This study was developed and designed with 
multidisciplinary clinical input as well as patient and lay 
input, to examine the process of recognition and dysphagia 
care provided to patients with PD who were admitted to 
hospital when acutely unwell. Organisational and clinical 
aspects of care were reviewed, and recommendations 
have been made to drive quality improvement in the care 
provided to future patients with dysphagia and PD.
Introduction 
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Study Advisory Group 
A multidisciplinary group of clinicians was convened to 
identify the objectives of the study and advise on the key 
questions to be asked of their peers. The Study Advisory 
Group (SAG) comprised physicians in acute medicine, 
neurology, palliative and geriatric medicine, speech 
and language therapists, physiotherapists, dietitians, 
pharmacists, specialist nurses, otolaryngology and 
gastrointestinal surgeons, rehabilitation specialists and 
lay and patient representatives. 
Study aim
To examine the pathway of care for patients with Parkinson’s 
disease (PD) who were admitted to hospital when unwell, 
and to explore multidisciplinary care and organisational 
factors in the process of identifying, screening, assessing, 
treating and monitoring of their ability to swallow. 
Objectives
The SAG identified specific objectives that would address 
the aim of the study. 
These included:
•	 Initial	assessment	and	recognition	of	dysphagia,	
including risk assessment and any delays in diagnosis
•	 Assessment	of	swallowing	
•	 Ongoing	management	of	dysphagia	with	regard	to	






diets, nutritional screening and ‘risk feeding’
•	 Medication	management,	including	pharmacological	
and non-pharmacological care of patients, and the 
availability of PD medications
•	 End	of	life	care,	where	appropriate
•	 Discharge/follow-up	arrangements,	including	
communication with relevant healthcare professionals 
•	 Organisational	factors	that	impacted	on	patient	outcomes
Study population and sampling criteria
Inclusion criteria
Adult patients aged 16 and over with PD who were acutely 
unwell and admitted to hospital between 7th January and 
3rd March 2019. Patients were identified by ICD10 codes for 











would be available for a review
•	 Patients	who	were	admitted	to	Level	3	(ICU/ITU)	critical	
care, as they may have been intubated
•	 Patients	who	were	admitted	to	independent	hospitals,	as	
this group of patients were unlikely to be acutely unwell.
Sampling criteria
From the whole group a maximum of four patients per 
hospital were randomly selected for inclusion, and a 
request was made to the treating clinician to complete a 
questionnaire.




NHS hospitals in England, Scotland, Wales and Northern 
Ireland were expected to participate as well as public 
hospitals in the Isle of Man, Guernsey and Jersey. 
Data collection
Patient/carer online survey
An open-access, anonymous survey was circulated online to 
allow patients with PD who were admitted to hospital with 
dysphagia, or their carers, to provide their views on the care 
received as an inpatient. A link was sent to a wide group 
of stakeholders to disseminate via their local and national 
service user and carer networks.
Spreadsheet
A pre-set spreadsheet was provided to every local reporter 
to identify all patients meeting the study criteria during 
the study time period. From this initial cohort sampling for 
inclusion in the study took place.
Questionnaires
Two questionnaires were used to collect data for this study: 
a clinician questionnaire relevant to each patient and an 
organisational questionnaire for each participating hospital.
Clinician questionnaire
This questionnaire was sent electronically to the consultant 
responsible for the care of the patient at the time of their 
hospital admission. Information was requested on the 
patient’s initial clerking, assessment of swallowing, ongoing 
care, dietary modifications, medicine optimisation, ‘risk 
feeding’ decisions, end of life care and discharge/death (if 
applicable).
Organisational questionnaire
This questionnaire was disseminated to each hospital with 
patients in the study and included questions on pathway/
protocols and the provision of services relating to dysphagia.
Case notes
Copies of case note extracts were requested for each case 











resuscitation (DNACPR) forms/treatment escalation forms 
	•	 Discharge	summary
•	 Clinic	letters	for	one	year	prior	to	the	index	admission
As the number of patients identified as experiencing 
dysphagia was lower than expected, following receipt of the 
first 350 sets of notes, the case note request was amended 
to focus on those patients where the clinician indicated that 





Peer review of the case notes and 
questionnaires
A multidisciplinary group of case reviewers was recruited 
to peer review case notes. The group of case reviewers 
comprised consultants, clinical nurse specialists and allied 
healthcare professionals from the following specialties: 
speech and language therapy, geriatric medicine, acute 
medicine, palliative care, neurology, nursing, dietetics, 
physiotherapy, pharmacy and surgery. 
1METHOD AND DATA RETURNS
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Questionnaires and case notes were anonymised by non-
clinical staff at NCEPOD. All patient identifiers were removed. 
Neither the clinical co-ordinators at NCEPOD, nor the case 
reviewers had access to patient identifiable information. 
After being anonymised, each set of case notes was 
reviewed by at least one reviewer within a multidisciplinary 
group. At regular intervals throughout each case review 
meeting, the chair allowed a period of discussion for each 
reviewer to summarise their cases and ask for opinions from 
other specialties or raise aspects of the case for discussion. 
Case reviewers answered a number of specific questions 
using a semi-structured electronic questionnaire and were 
encouraged to enter free-text commentary at various points.
The grading system below was used by the case reviewers to 
grade the overall care each patient received:
Good practice: A standard that you would accept from 
yourself, your trainees and your institution
Room for improvement: Aspects of clinical care that 
could have been better
Room for improvement: Aspects of organisational care 
that could have been better
Room for improvement: Aspects of both clinical and 
organisational care that could have been better
Less than satisfactory: Several aspects of clinical and/
or organisational care that were well below the standard 
that you would accept from yourself, your trainees and your 
institution
Insufficient data: Insufficient information submitted to 
NCEPOD to assess the quality of care
Information governance
All data received and handled by NCEPOD complied with 
all relevant national requirements, including the General 
Data Protection Regulation 2016 (Z5442652), Section 251 
of the NHS Act 2006 (PIAG 4-08(b)/2003, App No 007), 
PBPP (1718-0328) and the Code of Practice on Confidential 
Information.
Each patient was given a unique NCEPOD number. All 
electronic questionnaires were submitted through a 
dedicated online application. Prior to any analysis taking 
place, the data were cleaned to ensure that there were no 
duplicate records and that erroneous data had not been 
entered. Any fields that contained data that could not be 
validated were removed.
Data analysis
Following cleaning of the quantitative data, descriptive 
data summaries were produced. Qualitative data collected 
from the case reviewers’ opinions and free-text answers in 
the clinician questionnaires were coded, where applicable, 
according to content to allow quantitative analysis. The 
data were reviewed by NCEPOD clinical co-ordinators, a 
clinical researcher and researcher to identify the nature and 










The findings of the report were reviewed by the SAG, 
case reviewers, and the NCEPOD Steering Group including 
clinical co-ordinators, trustees and lay representatives prior 
to publication. In addition, the recommendations were 
independently edited, and the report proofread, by two 
external proof-readers.




In total 11,584 patients were identified as meeting the 
study inclusion criteria (Figure 1). Subsequently 227 were 
excluded, including 94 patients who were identified as not 
having PD. Up to four patients per hospital were randomly 
selected for review of their care, which resulted in a 
sample of 878 patients. Clinician questionnaires were sent 
for completion for all this sample. An initial request was 
made for the case notes to be returned for all 878 patients 
however, this was subsequently streamed to request case 
notes for just those patients where the clinician completing 
the clinician questionnaire indicated that the patient 
experienced dysphagia during the admission. This resulted a 
total of 562 sets of case notes being requested. 
In total, 505/878 (57.5%) clinician questionnaires were 
included in the analysis and 344/562 (61.2%) sets of 
case notes were peer reviewed by the case reviewers; this 
included 126 patients with dysphagia. 
Patients were identified for inclusion using the ICD10 
codes G20 (Parkinson’s disease) and G21 (secondary 
parkinsonism). Of the 878 patients sampled for clinician 
questionnaire completion, 50 had an ICD10 code of 
G21. While patients with both Parkinson’s disease and 
secondary parkinsonism were included in the study, the term 
Parkinson’s disease is used throughout the report.
Organisational data
Organisational questionnaires were returned from 177/283 
(62.5%) hospitals.




Figure 1.1. Data returns and study inclusion for questionnaires and case note review
11,584 patients reported
878 selected cases
227 excluded (94 because the 
patient did not have PD)
562 case notes requested
443 case notes returned
344 case notes reviewed 126 dysphagia cases reviewed
505 clinician questionnaires 
returned
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This chapter describes the data collected from patients with 
Parkinson’s disease (PD) and carers via the online survey and 
gives their views on the provision of services for patients with 
dysphagia. 
Fifty-seven respondents stated that they had been admitted to 
hospital during the previous year, 45 of whom also indicated 
that they had swallowing difficulties. Of these, 26 people 
completed the remainder of the survey with 18/26 surveys 
completed by a relative or carer and 7/26 by a person with PD. 
The age of the person with PD ranged between 52-89 years, 
and the length of time since diagnosis ranged between a “very 
recent” diagnosis to 17 years.
The management of inpatient swallowing difficulties was rated 
as ‘good’ or ‘adequate’ by 10/25 respondents and as ‘poor’ or 
‘unsatisfactory’ by 15/25 respondents (Figure 2.1). Seventeen 
respondents highlighted issues related to food provision: six 
commented that it was either inedible or there was limited 
help and three commented that there was no assessment/
lack of knowledge, in so far as no one asked what food 
would be acceptable or about whether they could swallow 
foods or medications.
Seventeen patients saw a speech and language therapist 
while in hospital. For 10/17 people this was for swallowing, 
for 4/17 for both speech and swallowing, and for three 
people, for speech alone.
In order to maintain a ‘safe swallow’, patients should sit 
upright at 90 degrees when eating and drinking, and not 
eat when slouching or lying down.14 Eleven respondents 
reported that food, drink or medication was given while the 
patient was lying down.
Problems with eating, drinking or swallowing medication 
while in hospital were not taken seriously by the healthcare 












Figure 2.1. Rating of the management of the swallowing problems while 
in hospital
Patient and carer survey data 







1. 10/25 respondents to the online survey rated the 
management of swallowing difficulties as ‘good’ 
or ‘adequate’ and 15/25 respondents rated the 
management as ‘poor’ or ‘unsatisfactory’ 
2. 11 patient/carer respondents to the online survey 
reported that food, drink or medication was given 
 while the patient was lying down 
3. 12/25 respondents to the online survey indicated 
that problems with eating, drinking or swallowing 
medication while in hospital were not taken seriously 




This chapter provides an overview of the sampled study 
population from the data collected from hospitals.
Figure 3.1 shows the age and gender distribution of patients 
included in this study population. The average age of men 
was 78.3 years and of women 79.9 years. In total, 312/504 
(61.9%) of the study sample were men and 191/504 (37.9%) 
were women.
Identification of dysphagia in the sample 
population
Clinicians completing a questionnaire indicated that 83/412 
(20.1%) patients had dysphagia at some point during their 
hospital admission (Table 3.1).
In addition, there were several questions in the clinician 
questionnaire relating to indicators of, or the presence of, 













Table 3.1 Clinician reported that the patient had 
dysphagia at some point during the admission





Subtotal 412  
Unknown 59  
Not answered 34  












Figure 3.1. Age and gender of the study population












Male (n=309)        Female (n=190)
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There were 154/505 (30.5%) patients where the answer 
to at least one of these questions was ‘yes’, indicating 
dysphagia was present during the admission, perhaps more 
commonly than was initially recognised (Table 3.2).
A similar percentage of patients were identified from 
their case notes, assessed by the case reviewers, as having 
dysphagia when presenting to hospital (83/277; 30%) (Table 
3.3). It should be noted that the 344 case notes selected for 
peer review were skewed towards patients who either had 
indicators of dysphagia at or during the admission or required 
modified diet/fluids or missed/altered their medications.
Following peer review of the notes, the case 
reviewers indicated that overall 126/312 (40.4%) 
patients had dysphagia at some point during the 
admission (Table 3.4). 
Stage of Parkinson’s disease
At the time of admission, the mean time since diagnosis of 
PD in this study population was 6.7 years (range 0-27 years). 
A clinical scale for staging PD has been recommended as a 
pragmatic method to plan for care throughout the disease 
process.15 The Hoehn and Yahr Scale was one of the first 
tools to measure the extent of disability in, and monitor 
progression of, PD16 and the Movement Disorder Society 
- Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) 
combines elements from multiple scales to provide a more 
comprehensive understanding of the disease, including its 
non-motor features17 (Appendix 2). Admitting clinicians 
were asked to retrospectively indicate the severity of PD in 
this study population. The ‘Stages of Care’ rating was most 
frequently completed (417/505; 82.6%) with most patients 
in the ‘maintenance’ or ‘complex’ stage at the time of 
admission (Table 3.5). 
3STUDY POPULATION
Table 3.2. Indicators or presence of dysphagia during 
the admission





Total 505  
Clinician questionnaire data
Table 3.3 Dysphagia was present in this patient on 
arrival at hospital





Subtotal 277  
Unable to answer 48  
Not answered 19  
Total 344  
Case reviewer data
Table 3.4 The patient had dysphagia at some point 
during the admission 





Subtotal 312  
Unable to answer 32  
Total 344  
Case reviewer data
Table 3.5 Stage of Parkinson’s disease at the time of 
admission






End stage 80 19.2
Subtotal 417  
Unknown 88  
Total 505  
Clinician questionnaire data
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Table 3.6 shows the Hoehn and Yahr Scale at the time of 
admission. The MDS-UPDRS score appeared to be of limited 
use (10/505; 2.0% responses – data not shown).
Dysphagia can occur at any stage of PD although is more 
likely as the disease progresses. In this study, indicators of 
dysphagia during the admission occurred each stage of 
PD with 30/76 (40.5%) in stage 5 compared with 18/123 
(14.4%) of those with no indicators of dysphagia (Figure 
3.2). Similarly, 49/133 (36.8%) of patients with indicators 
of dysphagia during the admission were in the end stage of 
Parkinson’s disease compared with 31/284 (10.9%) of those 
with no indicators of dysphagia (Figure 3.3). 
3STUDY POPULATION
Table 3.6 Hoehn and Yahr Scale at the time of 
admission
 Number of 
patients
%
Stage 1 18 9.0
Stage 2 23 11.6
Stage 3 39 19.6
Stage 4 71 35.7
Stage 5 48 24.1
Subtotal 199  
Unknown 306  









Figure 3.2. Hoehn 
and Yahr Scale by the 
presence of dysphagia 
during the admission 
Clinician questionnaire 
data










Hoehn and Yahr score
Indicators of dysphagia (n=76)        No indicators of dysphagia (n=123) 
Figure 3.3. Stage of 
Parkinson’s disease 
by the presence of 



















Stage of Parkinson’s disease
Indicators of dysphagia (n=133)        No indicators of dysphagia (n=284) 
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Care under a Parkinson’s disease service
NICE Quality Standard 1649 stipulates that patients should 
have a PD nurse specialist as a point of contact with 
specialist services to facilitate continuity of care, information 
sharing, advice and support. This contact also ensures 
patient needs are proactively reviewed and addressed. 
Consultants completing the clinician questionnaire reported 
that 307/397 (77.3%) patients were under the care of a PD 
service prior to their admission. However, case reviewers 
found no evidence of documentation of this information 
in 180/316 (57.0%) cases reviewed. Lack of such 
documentation could lead to incomplete discharge planning 
and handover back to the Parkinson’s disease service at the 
end of the hospital stay.
According to a recent systematic review, patients with PD 
are about 1.5 times more likely to be admitted to hospital 
compared with age matched healthy peers.18 Common 
reasons for acute admission to hospital are respiratory and 
urinary tract infections (22%), worsening motor features 
of PD (19%) and falls (13%). Aspiration pneumonia is also 
common in those presenting with respiratory infection, 
primarily due to dysphagia. Urgent or emergency admissions 
from residential and care homes are usually due to falls. 
The most common reason for admission to hospital in this 
study population was falls (142/505; 28.1%) and frailty 
(63/505; 12.5%), followed by symptoms suggestive of 
cardiorespiratory involvement (with cough and shortness 
of breath). Some patients were admitted with multiple 
symptoms (Table 3.7).
While most patients were admitted from home (368/495; 
74.3%), 52/495 (10.5%) were admitted from a nursing 
home and 48/495 (9.7%) a residential home (Table 3.8). 
Most patients in this study were admitted as an emergency 
(445/500; 89.0%) reflecting the presenting features listed. 










Elective admission 27 5.3
Abdominal pain 26 5.1
Vomiting 19 3.8
Drowsiness 18 3.6
Chest pain 17 3.4
Constipation/diarrhoea 17 3.4
Cerebrovascular disease 15 3.0
Other 54 10.7
Answers may be multiple; n=505
Clinician questionnaire data
3STUDY POPULATION
Table 3.8 Where the patient was admitted from




Nursing home 52 10.5
Residential care home 48 9.7
Another hospital 17 3.4
Other 10 2.0
Subtotal 495  
Unknown 10  
Total 505  
Clinician questionnaire data
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In keeping with the presenting features listed in Table 3.7, 
most patients required admission to a medical specialty 
(383/505; 75.8%) and were placed either in a medical 
assessment unit or a medical ward (Table 3.9). The medical 
specialties receiving these patients were general medicine 
(137/505; 27.1%) and geriatric medicine (106/505; 21.0%). 
Surgery requiring sedation, general or regional anaesthesia 
was undertaken in 79/493 (16.0%) patients. 
Most patients had additional comorbidities (453/495; 
91.5%); with dementia, cerebrovascular disease, diabetes 
and chronic pulmonary disease being most frequent 
(Figure 3.4) and 362/451 (80.3%) patients had more than 
one comorbidity.
3STUDY POPULATION
Table 3.9. Type of ward to which the patient was first 
admitted 
 Number of 
patients
%
Medical assessment unit 273 54.7
Medical ward 92 18.4
Surgical ward 82 16.4
Surgical assessment unit 21 4.2
High dependency care 4 <1
Other 27 5.4
Subtotal 499  
Unknown 6  













Figure 3.4 Comorbidities 







































































































































There were 30/409 (7.3%) patients who had a history of 
aspiration pneumonia prior to their admission. Of these 
30 patients, 18/24 patients had dysphagia. Of those 
without aspiration pneumonia, 48/320 (15%) had 
dysphagia. (Table 3.10)
4. 83/412 (20.1%) patients had dysphagia at some point 
during their hospital admission, in the view of clinicians 
completing the questionnaire
5. 154/505 (30.5%) patients had indicators of dysphagia 
during the admission, when data from multiple 
questions in the clinician questionnaire were combined
6. 83/277 (30%) patients had dysphagia when presenting 
to hospital documented in the case notes 
7. 307/397 (77.3%) patients were under the care of a 
Parkinson’s disease service prior to their admission 
8. 180/316 (57%) sets of case notes contained no evidence 
that patients with Parkinson’s disease had a named 
contact with their Parkinson’s disease service 
9. 30/409 (7.3%) patients had a history of aspiration 
pneumonia prior to their index admission. Of these 
30 patients, 18/24 patients had dysphagia. Of those 




Clinician questionnaire data  
Table 3.10 History of aspiration pneumonia by the presence of 
dysphagia during the admission





% Number of 
patients






Yes 18 27.3 6 2.2 24 6 30
No 48 72.7 272 97.8 320 59 379
Subtotal 66  278  344 65 409
Unknown 17  51  68 28 96
Total 83  329  412 93 505
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This chapter presents data on the recognition of and dysphagia 
care provided from referral to the point of admission. 
Referral
A referral letter was available for 77/386 (19.9%) patients. 
The referral letter commonly included information about the 
patient’s medical care history (64/72), comorbidities (55/72) 
and current medications (51/72). However, information that 
was not shared as often included details of the level of 
dysphagia risk (7/72), action plans in the community (8/72) 
and advance decision planning (3/72) (Figure 4.1).
Since dysphagia can occur at every stage of PD it is important 
to assess and communicate its presence in a referral letter. 
Case reviewers found that information relating to dysphagia 
was not available in 20/79 sets of notes of patients who were 
known to have dysphagia at the time of arrival (Table 4.1).
Referral, initial assessment and admission
4
Figure 4.1  
Information included 
in the referral letter


















of the PD 
Level of risk- 
community 














Information included in the referral letter
Case reviewer data 


















Yes 59 12 71 7 78
No 20 72 92 35 127
Subtotal 79 84 163 42 205
Unable to answer 3 1 4 14 18
NA – no dysphagia on arrival 1 109 110 11 121
Total 83 194 277 67 344
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Initial assessment
Activities of daily living
Patients with PD can have a variety of symptoms that 
interfere with activities of daily living and their ability to 
live independently. It is therefore important to identify 
deterioration in motor function and co-ordination early and 
at every opportunity. Similarly, dysphagia is an important 
contributor to the deterioration in quality of life. 
Clinicians returning a questionnaire reported that an 
assessment was made on arrival of how the person was 
managing at home for 388/479 (81.0%) patients, and 
the patient’s medication history, and their ability to take 
it, for 363/479 (75.8%) patients. However, an assessment 
of whether the patient had symptoms of dysphagia was 
made for only 179/479 (37.4%) patients. The ability to 
continue with normal diet and fluid intake, which is an 
indicator of dysphagia, was assessed for 287/479 (59.9%) 
patients. Similarly, assessment of dehydration and difficulty 
in controlling saliva, were assessed in 222/479 (46.3%) and 
62/479 (12.9%) patients respectively (Table 4.2). 
Presence of dysphagia
There was evidence in the case notes that 78 patients 
presented with information relating to their current level of 
dysphagia (Table 4.3). In the opinion of case reviewers 58/78 
patients had their dysphagia managed appropriately. 
There was evidence in the case notes relating to the initial 
assessment of the presence of dysphagia in only 123/312 
(39.4%) patients, while a similar number of patients 
(133/335; 39.7%) reported difficulty with speech. All were 
more likely to be assessed when dysphagia was recognised 
to be present during the admission (Figure 4.2 overleaf).
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Table 4.2 Assessments undertaken 
 Number of 
patients
%
How the patient was managing at 
home
388 81.0
Medication history and compliance 363 75.8
Whether the patient was eating 
and drinking a normal diet prior to 
admission
287 59.9
Whether the patient had difficulty 
with speech/communication
255 53.2
Whether the patient was admitted 
with dehydration
222 46.3
Mental capacity 218 45.5
Whether the patient had 
symptoms of dysphagia on 
admission
179 37.4
Any side effects associated with 
medications
114 23.8
Whether the patient had difficulty 
with controlling saliva
62 12.9
None of the above 46 9.6
Subtotal 479  
Unknown 26  
Total 505  
Answers may be multiple; n=479
Clinician questionnaire data
Table 4.3 Evidence in the case notes that the patient 
arrived with information relating to their current 
level of dysphagia 





Subtotal 205  
Unable to answer 18  
NA - dysphagia not present on 
arrival
121  
Total 344  
Case reviewer data
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Case note reviewers indicated there was a delay in recognising 
dysphagia at initial assessment in 28/141 (19.9%) of the cases 
reviewed (Table 4.4). Where there was a delay, this affected 
the outcome in 6/19 patients, most commonly manifesting as 
lower respiratory infection or aspiration pneumonia. 
Screening for dysphagia
Early screening for dysphagia helps in establishing the 
need for further assessment of risk of complications, 
including dehydration and malnutrition. NICE Quality 
Standard 219 for the care of adults following a stroke stated 
that swallow screening should be undertaken 
within four hours of admission. Even though it does not 
appear in the 2016 update, it is still supported by NICE at 
local level. Although not specific to patients with PD, this 
quality standard was adopted into the study. There was 
evidence in the case notes that a swallowing screen was 
undertaken within four hours of arrival for 44/316 (13.9%) 
patients. These included 24/75 patients who were known to 
have dysphagia at admission but missed in a further 51/75 
patients who were assessed to have dysphagia on arrival 
(Table 4.5 overleaf). 
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Reviewers found evidence in the case notes that referral to 
speech and language therapy was made following a swallow 
screen on arrival for 51/209 (24.4%) patients (Table 4.6). They 
were of the opinion that a further 36/132 (27.3%) patients 
should have been referred at this stage.
In the opinion of the case reviewers, the initial assessment of 
patients was satisfactory in 206/287 (71.8%) cases reviewed. 
The main reason case reviewers rated the initial assessment 
as not satisfactory, was that the swallow assessment was 
incomplete or not undertaken at all in 60/81 patients, or not 
actioned when the patient had difficulty swallowing in 23/81 
cases reviewed. For three patients both these steps were not 
undertaken satisfactorily even after dysphagia was recognised.
Admission
Indicators of dysphagia at admission
Based on data from the clinician questionnaire, 96/449 
(21.4%) patients had indicators of dysphagia on admission. 
The most common indicators were difficult or slow chewing 
and swallowing and coughing or choking (Figure 4.3 overleaf).
Case reviewer data






















Yes 24 18 42 1 1 44
No 51 161 212 43 17 272
Subtotal 75 179 254 44 18 316
Unable to answer 8 15 23 4 1 28
Total 83 194 277 48 19 344
Table 4.6 The patient was referred to speech and 
language therapy following a swallow screening on 
arrival





Subtotal 209  
Unable to answer 11  
NA 124  
Total 344  
Case reviewer data
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A 64-year-old patient was admitted with inability to 
cope at home. The patient was noted to be coughing 
on water and medicines. However, no swallow 
screening was performed at admission and the patient 
was made ‘nil by mouth’ by the clerking doctor who 
suggested referral to speech and language therapy. 
By the next day the patient was drowsy and confused 
due to a combination of dehydration, missed oral 
medications and lack of any alternative medications 
administered.  
Case reviewers were of the opinion that these 
complications could have been avoided by undertaking 
prompt swallow screening, referral to speech and 
language therapy and prescription of intravenous fluids 
and suitable medications in liaison with the Parkinson’s 
disease specialist team and pharmacy.
C A S E   S T U D Y   1
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History of coughing/choking
Frequent coughing, choking or nasal regurgitation of food 
when swallowing are important symptoms of dysphagia 
and dehydration is common in patients with dysphagia. A 
history of choking was present in 33/406 (8.1%) patients 
and signs of dehydration assessed in 299/443 (67.5%) 
patients, primarily by monitoring fluid balance (191/443, 
43.1%) and urine output (105/443, 23.7%) (data not 
shown), although there was no documentation for 144/443 
(32.5%) patients (Table 4.7).
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Figure 4.3. Indicators 
of dysphagia on 
admission 




*  Other responses provided 
– Wet voice quality, 
unexplained temperature 
spikes, food sticking in 
throat, hoarse voice, 
feeling of obstruction, 
avoiding particular foods 
e.g. dry/hard, heartburn, 
regurgitation of 
undigested food, avoiding 
social occasions, frequent 
throat clearing all <5 
patients
Indicators of dysphagia
Difficult, slow chewing or swallowing
Coughing or choking before, during or after swallowing
Change to consistency to food e.g. soft/puree diet
Difficulty controlling food or liquid in the mouth
Recurrent chest infections
Unintentional weight loss
Difficulty in swallowing pills
Prolonged time to complete a meal
Change in respiration pattern
Drooling
Drowsy
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Table 4.7 A history of choking and hydration assessment






% Number of 
patients
%
Yes 33 8.1 299 67.5
No 373 91.9 144 32.5
Subtotal 406  443
Unknown 99  62
Total 505  505
Clinician questionnaire data
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Referral to speech and language therapy (covered in 
further detail in Chapter 5)
NICE Quality Standard 1649 for patients with PD includes 
a referral to the speech and language therapy (SLT) team if 
problems are identified with communication, swallowing or 
saliva. Consultants completing the clinician questionnaire 
reported that on admission 96/377 (25.5%) patients were 
referred to SLT, and in 87 patients this was for dysphagia 
(Table 4.8).
Non-motor assessments
While the motor manifestations of PD are most obvious 
from early disease and form an important part of its 
diagnostic criteria, other features collectively called non-
motor symptoms, can be obscure but still have a significant 
impact. These comprise dementia related to PD, orthostatic 
hypotension, drooling of saliva, depression, impulse 
control disorder, psychotic symptoms and sleep disorders. 
Medications given for PD can produce or aggravate some 
of these features, such as orthostatic hypotension, impulse 
control disorder, hallucinations and delusions. In patients 
with PD and dementia up to 20% have been noted to have 
dysphagia.20 Since many of these non-motor symptoms can 
compromise swallowing and nutrition, they require prompt 
identification and multi-professional collaboration to achieve 
optimal control. 
Cognitive assessment was most often completed at 
admission (322/460; 70%), while mental health history and 
assessment were completed in 139/431 (32.3%) patients 
and 196/423 (46.3%) patients respectively (Table 4.9). 
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Table 4.8 The patient was referred to speech and 
language therapy on admission




Yes – for dysphagia 72 19.1
Yes – for both dysphagia and 
communication
15 4.0
Yes – for communication 9 2.4
Subtotal 377  
Not applicable 97  
Unknown 31  
Total 505  
Clinician questionnaire data
A 76-year-old patient with Parkinson’s disease 
was admitted with clinical suspicion of aspiration 
pneumonia. The patient was not assessed for dysphagia 
and swallow screening was missed at admission. Over 
the next 48 hours, the patient became less responsive 
and was transferred to critical care with sepsis.  
Case reviewers were of the opinion that timely swallow 
screening, referral to speech and language therapy 
and an appropriate plan for nutrition, hydration and 
administering medications could have prevented these 
complications.
C A S E   S T U D Y   2
Clinician questionnaire data  
Table 4.9 Non-motor assessments at admission 







% Number of 
patients
% Number of 
patients
%
Yes 139 32.3 322 70.0 196 46.3
No 292 67.7 138 30.0 227 53.7
Subtotal 431 460 423
Unknown 74 45 82
Total 505 505 505
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Carers can be an important source of information in the 
assessment and ongoing care of patients, especially for 
those patients with cognitive impairment. Case reviewers 
found evidence in the case notes that family members 
and/or carers provided information relevant to a patient’s 
admission in 208/330 (63.0%) cases.
Medication (covered in further detail in Chapter 8) 
Timely administration of medications for PD helps with 
symptom control. The Parkinson’s disease UK Medicines 
Optimisation Consensus Statement8 and NICE Quality 
Standard 1649 recommend that patients in hospital should 
take levodopa within 30 minutes of their individually 
prescribed administration time, as missed doses can lead to 
worsening symptoms and serious complications, resulting in 
a negative impact on quality of life and prolonged hospital 
stay. Missed doses could also exacerbate dysphagia, which 
may impair the ability to take subsequent doses, leading to 
progressive deterioration. 
Consultants completing the clinician questionnaire reported 
that 81/283 (28.6%) patients admitted via the emergency 
department missed one or more doses of medication. In 
addition, for a further 158/505 (31.3%) patients it was 
unclear whether they had missed a dose, highlighting the 
importance of good documentation (Table 4.10). 
When a patient is unable to swallow, or it is considered 
unsafe to allow oral medication, alternative routes or 
drugs should be considered. Any substantial changes to 
medications should be done in consultation with the PD 
specialist team, pharmacist, patient, family and/or carers. 
Of the 114 responses recorded as to why medication was 
not given, 21/114 (18.4%) were due to a clinical suspicion 
of dysphagia and 20/114 (17.5%) were due to a decision to 
keep the patient ‘nil by mouth’ (Table 4.11).
Medication history was most often verified on admission 
via the hospital pharmacist (253/423; 59.8%) or via a family 
member or carer (152/423; 35.9%) (Table 4.12). There was 
evidence in the case notes that 291/329 (88.4%) patients that 
they presented with information relating to their present drug 
dose and mode of administration (Table 4.13 overleaf). 
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Table 4.10 Doses of medication were missed, 
for those patients admitted via the emergency 












Clinician questionnaire data  




Concerns about dysphagia/ known 
dysphagia
21 18.4
Patient ‘nil by mouth’ 20 17.5
Clinical decision to not administer 
(details not noted)
20 17.5
Drug not prescribed/prescribed 
late
13 11.4
Drug was not available on ward 13 11.4
Patient arrived out of hours 10 8.8








Hospital pharmacist 253 59.8
Family member/carer 152 35.9
GP referral letter 53 12.5





Answers may be multiple; n=423
Clinician questionnaire data  
32
Nutritional screening 
NICE Clinical Guideline 32 on nutritional support for adults 
recommends that all hospital inpatients should be screened 
for the presence (or risk) of malnutrition on admission.5 
Screening should be repeated weekly for inpatients. Such 
screening should be undertaken with the aid of a validated 
screening tool. The Malnutrition Universal Screening Tool 
(MUST) was introduced in 2003 by the British Association of 
Parenteral and Enteral Nutrition (BAPEN) and supported by 
multiple organisations like the Royal College of Nursing and 
British Dietetic Association.13 It is also mentioned in NICE 
Quality Standard 24, which covers the care for adults who 
are malnourished or at risk of malnutrition in hospital or in 
the community.12
There were 69/152 (45.4%) hospitals in which there was no 
policy for the nutritional assessment of patients admitted 
with PD (Table 4.14).
Data from the clinician questionnaire indicated there was 
a record of nutritional screening undertaken on admission 
for 295/434 (68.0%) patients. The most commonly used 
method of nutritional screening was the MUST (226/287; 
78.7%) (Table 4.15). 
Case note reviewers found a record in the case notes of 
a nutritional screening being undertaken on admission 
in 162/336 (48.2%) cases reviewed. Where this was 
undertaken the case note reviewers indicated this was 
adequate in 136/157 (86.6%) patients. There was evidence 
in the case notes that a MUST score was calculated on 
arrival for 119/316 (37.7%) patients. In the opinion of 
the case reviewers the correct score was calculated for 
102/111 (91.9%) patients, and the correct action to be 
taken identified as a result of MUST screening for 100/109 
(91.7%) patients (Table 4.16). 
Table 4.13 Evidence in the case notes that the patient 
presented with information relating to their drug 
dosage and mode of administration





Subtotal 329  
Unable to answer 15  
Total 344  
Case reviewer data
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Table 4.14 Policy on nutritional assessment for all 
patients admitted with Parkinson’s disease





Subtotal 152  
Unknown 25  
Total 177  
Organisational data 
Table 4.15 Method of nutritional screening was used
 Number of 
patients
%
Malnutrition Universal Screening 
Tool (MUST)
226 78.7
Estimated weight 69 24.0
Family/carers 37 12.9
Other 44 15.3
Subtotal 287  
Unknown 8  
Total 295  
Answers may be multiple; n=287
Clinician questionnaire data
Table 4.16 A MUST score calculated on arrival





Subtotal 316  
Unable to answer 28  
Total 344  
Case reviewer data
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10. 20/79 sets of notes of patients who were known to 
have dysphagia at the time of arrival did not contain 
information relating to dysphagia 
11. An assessment of whether the patient had symptoms of 
dysphagia was made for 179/479 (37.4%) patients
12. 287/479 (59.9%) patients had their ability to continue 
with normal diet and fluid intake, which is an indicator 
of dysphagia, assessed at admission. Similarly, 
assessment of dehydration and difficulty in controlling 
saliva, were assessed in 222/479 (46.3%) and 62/479 
(12.9%) patients respectively
13. 123/312 (39.4%) patients had documented assessments 
of dysphagia at the initial assessment, while a similar 
number of patients (133/335; 39.7%) reported difficulty 
with speech
14. 44/316 (13.9%) patients had swallow screening 
undertaken within 4 hours of arrival. This missed 51/75 
patients who were known to have dysphagia on arrival
15. 51/209 (24.4%) patients were referred to speech 
and language therapy following swallow screening 
on arrival at hospital. The case reviewers were of the 
opinion that a further 36/132 (27.3%) patients should 
have been referred
16. 96/449 (21.4%) patients had indicators of dysphagia on 
admission. The most common indicators were difficult or 
slow chewing and swallowing and coughing or choking 
17. 96/377 (25.5%) patients were referred to speech and 
language therapy on admission, and in 87 patients this 
was for dysphagia
18. 81/283 (28.6%) patients admitted via the emergency 
department missed one or more doses of medication. 
For a further 158/505 (31.3%) patients it was unclear 
whether they had missed a dose. Of the 114 responses 
recorded as to why medication was not given, 21/114 
(18.4%) were due to a clinical suspicion of dysphagia 
and 20/114 (17.5%) were due to a decision to keep the 
patient ‘nil by mouth’ 
19. 69/152 (45.4%) hospitals did not have a policy for 
the nutritional assessment of patients admitted with 
Parkinson’s disease
20. 295/434 (68.0%) patients had a nutrition screen 
undertaken on admission as recorded in the clinician 
questionnaire. This was documented in the case notes of 
162/336 (48.2%) patients
21. There was evidence in the case notes that a Malnutrition 
Universal Screening Tool (MUST) score was calculated on 
arrival for 119/316 (37.7%) patients  
4REFERRAL, INITIAL ASSESSMENT AND ADMISSION
Key Findings
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On admission to hospital, if there are concerns about a 
patient’s ability to swallow safely or if they are unable to 
complete a swallow screening test, they should be promptly 
referred to the speech and language therapy (SLT) service for 
formal assessment and care of their dysphagia. 
While a ward-based clinical assessment of swallowing 
may be performed by SLT in patients with Parkinson’s 
disease (PD), there may be a need to make an instrumental 
assessment. Fibreoptic endoscopic evaluation of swallowing 
(FEES) uses a flexible endoscope to directly visualise the 
process of swallowing for different food consistencies and 
liquids. A videofluoroscopic swallowing study (VFSS) uses 
modified barium swallows with foods and fluids of different 
consistency to study the processes of swallowing. 
In this study, it was reported that there was a protocol for 
the screening for dysphagia in 88/161 (54.7%) hospitals, 
and 105/163 (64.4%) hospitals in which there was a 
protocol for the assessment of dysphagia (Table 5.1). 
Data from the clinician questionnaire showed a formal 
assessment of swallowing was undertaken during the 
admission for 117/457 (25.6%) patients. A formal 
assessment of swallowing was more likely to be 
undertaken in patients with indicators of dysphagia on 
admission (indicators of dysphagia on admission 67/93; 
72.0% vs. no indicators of dysphagia on admission 42/325; 
12.9%). Patients who, on review of the case notes were 
identified as experiencing dysphagia during the admission, 
were also more likely to have a formal assessment of 
swallowing (dysphagia during the admission 60/82; 73.2% 
vs. no dysphagia during the admission 33/300; 11.0%). 
For a majority of patients this assessment was undertaken as 
a clinical assessment of swallowing (111/115; 96.5%) and 
VFSS or FEES was used for just 8/115 (7.0%) patients. Data 
from the organisational questionnaire indicated VFSS was 
available and could be used for assessment of dysphagia 
in 157/170 (92.4%) hospitals, the average waiting time to 
access this service ranged between 1-105 days with a mean 
waiting time of 14 days.
Similar data from the case reviewers showed that there 
was evidence in the case notes of a formal assessment of 
swallowing undertaken during the admission for 100/335 
(29.9%) patients. Where such an assessment was not 
undertaken the case reviewers were of the opinion that 
one should have been undertaken for a further 51/200 
(25.5%) patients.
Based on the case notes, the reviewers indicated the 
presence of dysphagia was not assessed adequately during 
the admission for 93/218 (42.7%) patients (Table 5.2).
Formal swallowing assessment after admission
5
Organisational data 
Table 5.1 A protocol for the screening for and/or the 
assessment of dysphagia






% Number of 
hospitals
%
Yes 88 54.7 105 64.4
No 73 45.3 58 35.6
Subtotal 161  163  
Unknown 16  14  
Total 177  177  
Table 5.2 The presence of dysphagia assessed 
adequately during the admission





Subtotal 218  
Unable to answer 33  
NA 93  




Dysphagia was documented as a symptom at some point 
during the admission in 118/343 (34.4%) sets of case notes. 
Where dysphagia was documented in the case notes as a 
symptom during the admission, the case reviewers indicated 
this was cared for appropriately throughout the admission 
for 71/114 (62.3%) patients. The most common reasons for 
inappropriate dysphagia care related to poor documentation 
(11/43); a lack of SLT review (10/43); dysphagia not being 
assessed at all (8/43) or a delay in assessment (7/43).
Where it was documented as a symptom, in the opinion 
of the case reviewers there had been a delay in recognising 
dysphagia in 23/114 (20.2%) patients. The most common 
reason was a delay in or the lack of initial swallow screening 
for 13/23 patients or lack of recognition of the presence of 
signs and symptoms prior to admission for 10/23 patients.
Where there was a delay in recognising dysphagia, the 
reviewers were of the opinion that this affected the 
outcome for 6/18 patients. Four patients developed 
pneumonia and two patients were discharged with 
incomplete plans for community care.
Where dysphagia was not documented as a symptom, case 
reviewers found evidence that a diagnosis of dysphagia was 
missed for 16/209 (7.7%) patients.
22. 88/161 (54.7%) hospitals had a protocol for the 
screening of dysphagia, and 105/163 (64.4%) had a 
protocol for the assessment of dysphagia 
23. 117/457 (25.6%) patients had a formal assessment 
of swallowing undertaken during the admission as 
recorded in the clinician questionnaire
24. There was evidence in the notes that a formal 
assessment of swallowing was undertaken during the 
admission for 100/335 (29.9%) patients. Where such an 
assessment was not undertaken the case reviewers were 
of the opinion that one should have been undertaken 
for a further 51/200 (25.5%) patients 
25. Videofluoroscopic swallowing study was available in 
157/170 (92.4%) hospitals but only used in 5/115 
(4.3%) patients
26. Case reviewers indicated the presence of dysphagia was 
not assessed adequately during the hospital admission 
for 93/218 (42.7%) patients
27. Case reviewers found that there was a delay in 
recognising dysphagia in 23/114 (20.2%) of patients 
while they were in hospital
28. Where there was a delay in recognising dysphagia, case 
reviewers were of the opinion that this affected the 
outcome for 6/18 patients
5FORMAL SWALLOWING ASSESSMENT AFTER ADMISSION
A 77-year-old patient was admitted with episodes 
of choking and “difficulty in swallowing fluids and 
medications”. After initial screening and assessment by 
speech and language therapy services a feeding plan was 
put in place that included using nasogastric (NG) tube 
feeding. No mention was made of engaging with the 
patient, their family or carers about NG tube insertion or 
including them in the decision-making process.
Case reviewers were of the opinion that this patient 
would have benefited from a formal assessment using 
videofluoroscopy (VFSS) or fibreoptic endoscopy (FEES) 
depending on local resources. This would have helped 
in developing a robust long-term plan for managing 
dysphagia and its effects.
C A S E   S T U D Y  3
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Patients with Parkinson’s disease (PD) manifest a 
combination of symptoms requiring the support of multiple 
professional groups and services. Issues with mobility 
and function should be addressed by physiotherapists 
and occupational therapists (OTs). Difficulties with 
communication and the consumption of food and drink 
require help from speech and language therapists (SLTs) 
and dietitians. This multidisciplinary input is supported by 
NICE Quality Standard 164.9 The Parkinson’s UK website 
lists the following professionals as being of help in an 
individual’s care: GPs, Parkinson’s specialists, Parkinson’s 
nurse specialists, SLTs, OTs, dietitians, physiotherapists, 
pharmacists, psychologists and counsellors.21
Parkinson’s disease service
A specialist PD service was reported to be available in 
146/171 (85.4%) hospitals. Where a PD service was in 
place, a consultant led the service in 129/145 (89.0%) 
hospitals; this was either a geriatrician (74/128; 57.8%) or 
a neurologist (52/128; 40.6%). A PD specialist nurse led the 
service in 13/145 (9.0%) hospitals and a specialist PD nurse 
was employed in 123/171 (71.9%) hospitals from which a 
response was received. 
Availability of the multidisciplinary team 
members
On-site access to OT and physiotherapy was available in all 
hospitals from which an organisational questionnaire was 
received (177/177; 100.0%), SLT, dietetics and pharmacy 
services were available in 176/177 (99.4%) hospitals. A 
nutrition team was available in 143/177 (80.8%) hospitals.
 
SLT services were available during the normal weekday 
working hours (Monday to Friday, 8:00 to 18:00) in 
140/172 (81.4%) hospitals, and available seven days 
a week in a further 12/172 (7.0%) hospitals. In the 
remaining hospitals (20/172; 11.6%) services were 
provided for various durations of time and none had a 24/7 
service. A 24/7, on-site access to services was available for 
pharmacy in 58/168 (34.5%) hospitals, physiotherapy in 
21/171 (12.3%) and OT in 2/171 (1.2%) hospitals (Figures 
6.1-6.5 overleaf). All but two hospitals had an on-call 
pharmacist to help with medications when the pharmacy 
was closed. 
Consultants who completed the clinician questionnaire 
reported that physiotherapists were involved in the care of 
373/497 (75.1%) patients and SLTs for 119/497 (23.9%) 
patients. Specialist PD consultants and/or specialist nurses were 
involved for 160/497 (32.2%) patients. Other clinicians who 
contributed to the care of 132/497 (26.6% ) patients included 
acute care, elderly care, neurology, palliative care physicians, 
surgical teams and allied healthcare professionals (Table 6.1).
Multidisciplinary team involvement during 
the admission
6
Table 6.1 Healthcare professionals involved in the 
patient’s care during the admission






Occupational therapy 262 52.7
Speech and language therapy 119 23.9




Specialist Parkinson’s disease nurse 83 16.7
Nutrition team 16 3.2
None 7 1.4
Other 132 26.6
Subtotal 497  
Unknown 8  
Total 505  
Answers may be multiple; n=497
Clinician questionnaire data
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Figure 6.1 On-site access to speech and language therapy
Organisational data 
24/7 Normal working hours 
(e.g. 08:00-18:00) 
7 days/week



















 Figure 6.2 On-site access to dietitians and the nutrition team
Organisational data   
On-site access to services - dietitians and the nutrition team
Normal working hours 
(e.g. 08:00-18:00) 
7 days/week










Dietitian (n=170        Nutrition team (n=132) 
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Figure 6.4. On-site access to physiotherapy




On-site access to services - Physiotherapy
24/7 Normal working hours 
(e.g. 08:00-18:00) 
7 days/week
















Figure 6.3. On-site access to occupational therapy





On-site access to services - Occupational therapy
24/7 Normal working hours 
(e.g. 08:00-18:00) 
7 days/week





Referral to other healthcare professionals 
during the admission
A referral for physiotherapy was made for 240/323 (74.3%) 
patients, while 108/317 (34.1%) patients were referred to SLT 
and 97/324 (29.9%) patients were referred to the PD team 
(Table 6.2). Case reviewers considered that a further 46/187 
(24.6%) patients should have been referred to SLT and 
67/195 (34.4%) patients to the PD team (Table 6.3 overleaf). 
Analysing instances of multiple omitted referrals highlighted 
45 patients for whom a total of 114 referrals were not 
made: 27 patients had two missed referrals and a further 13 
patients had three missed referrals.










Figure 6.5. On-site access to pharmacy





On-site access to services - Pharmacy
24/7 Normal working hours 
(e.g. 08:00-18:00) 
7 days/week




Table 6.2 Specialties to which the patient was referred to during the admission









n % n % n % n % n % n %
Yes 108 34.1 73 22.6 10 3.2 169 53.0 240 74.3 97 29.9
No 209 65.9 250 77.4 303 96.8 150 47.0 83 25.7 227 70.1
Subtotal 317  323  313  319  323  324  
NA 23  13  26  7  7  3  
Unable to 
answer
4  8  5  18  14  17  




Timing of referrals 
Details of the point at which the patient was referred to other 
specialties, following admission, is shown in Figure 6.6.
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Table 6.3 Specialties to which the patient should have been referred to during the admission









n % n % n % n % n % n %
Yes 46 24.6 38 18.4 21 8.1 20 15.7 11 15.9 67 34.4
No 141 75.4 168 81.6 237 91.9 107 84.3 58 84.1 128 65.6
Subtotal 187  206  258  127  69  195  
Unable to 
answer
22  44  45  23  14  32  











Figure 6.6 Timing of referral to different specialties, following admission
















Time of referral by specialty
Speech and language 
therapy (n=113)
Dietetics (n=78) Occupational therapy 
(n=232)
Physiotherapy (n=333)
>24 hours        Between 24-48 hours        >48 hours        Other 
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Case reviewers indicated that there was a delay in referral 
to SLT in 25/96 patients, and a similar proportion in referral 
to dietetics (16/64 patients) (Table 6.4). Review of multiple 
delays in referral highlighted that 18 patients had a delay in 
referral to two or more specialties.
There was evidence of a delay in assessment following a 
referral to SLT for 27/102 (26.5%) patients and to dietetics 
in 18/66 (27.3%) (Table 6.5). Additionally, 24 patients had 
delays in 51 assessments, with three patients experiencing 
delays in assessment by three separate specialties. 
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n=number of patients
Case reviewer data
Table 6.4 A delay in referral to other specialties









n n n n n n
Yes 25 16 2 8 (5.2%) 18 (8.3%) 10
No 71 48 8 146 (94.8%) 200 (91.7%) 82
Subtotal 96 64 10 154 218 92
NA 10 0 0 1 1 0
Unable to 
answer
1 9 0 14 21 5
Total 107 73 10 169 240 97
n=number of patients
Case reviewer data
Table 6.5 A delay in assessment by other specialties









n (%) n (%) n (%) n (%) n (%) n (%)
Yes 27 (26.5%) 18 (27.3%) 3 (33.3%) 16 (10.3%) 20 (8.9%) 19 (21.8%)
No 75 (73.5%) 48 (72.7%) 6 (66.7%) 139 (89.7%) 204 (91.1%) 68 (78.2%)
Subtotal 102 66 9 155 224 87
NA 0 0 0 1 1 2
Unable to 
answer
6 7 1 13 15 8
Total 108 73 10 169 240 97
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Eating and drinking 
Data from the clinician questionnaire indicated that a 
decision to keep the patient ‘nil by mouth’, was made for 
108/490 (22%) patients following admission. 
This decision was made because of impending surgery, 
investigation or procedure for 51/104 (49.0%) patients. In the 
remaining 66 patients, the most common reason was that 
they had difficulty swallowing (22/66) or were too drowsy to 
have their swallow screened (19/66). There were also patients 
who had evidence of complications of dysphagia such as 
aspiration pneumonia (10/66) or choking (2/66) (Table 6.6). 
Nine patients had multiple reasons for being ‘nil by mouth’.
 
Of the 108 patients made ‘nil by mouth’, 23/108 (21.3%) 
had support with eating and drinking (either a nasogastric, 
nasojejunal or gastrostomy tube insertion) during the 
admission. A modified texture diet was indicated at any point 
during the admission for 41/95 patients, and thickened fluids 
for 30/96 patients. Fourteen patients made ‘nil by mouth’ 
on admission were ‘risk feeding’ prior to admission, and this 
was considered for a further 12/52 patients on or following 
admission.
Case reviewers were of the opinion that for patients kept ‘nil 
by mouth’ (n=83), medications were managed appropriately 
for 55/71 patients where it could be assessed (Table 6.7). 
A policy for assisting patients with eating and drinking 
who are unable to do so by themselves was in place in 
121/154 (78.6%) hospitals. Where a policy was in place, a 
staff member was identified who would be responsible for 
assisting patients in 95/114 (83.3%) hospitals.
There were 145/433 (33.5%) patients who required 
assistance with eating and drinking. Where help was 
required, it was available at all times for 80/135 (59.3%) 
patients, and someone was available to help sometimes for 
33/135 (24.4%) patients. No information was recorded for 
the remaining patients (22/135; 16.3%) (Table 6.8). 
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Surgery, investigation or procedure 
needed
51 49.0
Difficulty swallowing 22 21.2
Drowsy 19 18.3
Aspiration pneumonia 10 9.6





Answers may be multiple; n=104
Clinician questionnaire data
Table 6.7 Medication managed appropriately for 
patients ‘nil by mouth’





Unable to answer 12
Total 83
Case reviewer data
Table 6.8 Someone available to help with eating 
and drinking
 Number of 
patients
%
Yes - all the time 80 59.3
Yes – sometimes 33 24.4
Not recorded 22 16.3
Subtotal 135  
Unknown 10  
Total 145  
Clinician questionnaire data
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Where assistance with eating and drinking was available, it 
was most often provided by a healthcare assistant/nursing 
support worker (93/111; 83.8%), by family members 
(38/111; 34.2%) or other healthcare professionals (38/111; 
34.2%) (Figure 6.7).
The risk of malnutrition and its impact was assessed and 
documented for 180/399 (45.1%) patients. Action following 
this included the regular use of food/nutrition charts 
(58/180; 32.2%), dietitian referral (38/180; 21.1%), and 
the use of oral nutritional supplements (14/180; 7.8%). No 
action was indicated (including as a result of end of life/
palliative care) for 33/180 (18.3%) patients. 
Tube feeding
To provide support with nutrition and hydration, patients 
who cannot swallow may be considered for insertion 
of a feeding tube (nasogastric (NG), nasojejunal (NJ) or 
gastrostomy tube). 
Case reviewers found that 25/344 (7.3%) patients had a 
feeding tube inserted for the purpose of feeding to improve 
nutrition and hydration. Four patients had multiple tubes 
inserted. There was a delay in 8/29 of these procedures 
being undertaken.
Oral hygiene and care
A protocol for the care of oral hygiene was reported to be 
in place in 107/148 (72.3%) hospitals. Where this was in 
place, it designated who was responsible for oral hygiene 
in 78/99 hospitals.
Data from the clinician questionnaire indicated that 
216/354 (61.0%) patients had their oral hygiene assessed 
by nursing staff. 
Case reviewers indicated that for 160/298 (53.7%) patients 
there was no evidence in the notes that the patient’s oral 
hygiene was cared for during the admission (Table 6.16). 
Where there was evidence, case reviewers were of the opinion 
that this was appropriate for 114/120 (95.0%) patients. 













Figure 6.7 People 
assisting the patient 
to eat or drink 

























Multidisciplinary team (MDT) meetings
It was reported from 75/168 (44.6%) hospitals that 
specialist MDT reviews took place for patients admitted 
with PD. In these hospitals there was also variation in 
membership of the MDT with 32/73 reporting presence of 
SLT, 28/73 presence of dietetics and 19/73 nutrition team 
members. (Figure 6.8).
The patient’s care was reviewed at an MDT meeting 
during the admission for 221/426 (51.9%) patients (Table 
6.9). The SLT team were represented at 43/221 (19.5%) 
meetings, of which 22/33 were when the patient was 
known to have dysphagia (Figure 6.9 overleaf). A record 
this review was documented in the case notes of for 
144/214 (67.3%) patients. 










Figure 6.8 Members of the multidisciplinary team for patients with Parkinson’s disease 
Answers may be multiple; n=73


























Table 6.9 The patient’s care was reviewed at an MDT 
meeting during the admission





Subtotal 426  
Unknown 50  
NA – elective surgical admission 29  
Total 505  
Clinician questionnaire data
A 79-year-old patient was admitted with urosepsis. 
The GP referral letter commented on their ongoing 
dysphagia and clearly documented their medication. 
Following admission, the patient was seen on the 
first day by the Parkinson’s disease team, speech and 
language therapy and physiotherapy. The following 
day a multidisciplinary team meeting was undertaken, 
and the specialty registrar documented that the 
patient’s relatives had been informed of the ongoing 
management plan with respect to the patient’s care 
and were in agreement with the plan.
The reviewers considered this to be excellent 
care and what should be expected with regard to 
multidisciplinary team input.
C A S E   S T U D Y   4
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The case reviewers reported that an appropriate MDT 
discussion was undertaken during the patient’s admission 
for 158/246 (64.2%) patients (Table 6.10). There was little 
difference in whether an appropriate MDT discussion was 
undertaken between patients with dysphagia (62/100; 
62.0%) or without dysphagia (91/130; 70.0%).
Care planning for a complex condition such as PD requires 
close collaboration with the patient, their family, carers and 
the hospital teams. In 245/273 (89.7%) sets of case notes 
reviewed, the case reviewers were of the opinion that there 
was adequate shared decision-making between the patient 
and healthcare professionals; and in 229/251 (91.2%) cases 
between the patient’s family and healthcare professionals 
(Table 6.11).























































































































Participants in the multidisciplinary team
Dysphagia (n=52)        No dysphagia (n=127)
Case reviewer data
Table 6.11 Adequate shared decision-making 
between the patient, the patient’s family and 
healthcare professionals






% Number of 
patients
%
Yes 245 89.7 229 91.2
No 28 10.3 22 8.8
Subtotal 273  251  
Unable to 
answer
71  93  
Total 344  344  
Table 6.10 An appropriate MDT discussion was 
undertaken during the admission





Subtotal 246  
NA 22  
Unable to answer 76  
Total 344  
Case reviewer data
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29. On-site access to occupational therapy and 
physiotherapy was available in all hospitals from which 
an organisational questionnaire was received (177/177; 
100.0%)
30. Speech and language therapy, dietetics and pharmacy 
services were available in 176/177 (99.4%) hospitals
31. A nutrition team was available in 143/177 (80.8%) 
hospitals 
32. Parkinson’s disease consultants and/or specialist nurses 
were involved for 160/497 (32.2%) patients 
33. Referral for physiotherapy was made for 240/323 
(74.3%) patients, while 108/317 (34.1%) were referred 
to speech and language therapy and 97/324 (29.9%) 
patients were referred to the Parkinson’s disease team
34. The reviewers were of the opinion that a further 46/187 
(24.6%) patients should have been referred to speech 
and language therapy and 67/195 (34.4%) patients to 
the Parkinson’s disease team
35. Analysing instances of multiple omitted referrals 
highlighted 45 patients for whom a total of 114 referrals 
were not made: 27 patients had two missed referrals and 
a further 13 patients had three missed referrals
36. Where patients were referred, case reviewers indicated 
there was a delay in referral to speech and language 
therapy in 25/96 patients and delay in referral to 
dietetics in 16/64 patients
37. A policy for assisting patients with eating and drinking 
who are unable to do so by themselves was in place in 
121/154 (78.6%) hospitals 
38. 160/298 (53.7%) patients had documented evidence in 
the case notes that oral hygiene was managed during 
their admission 
39. Specialist multidisciplinary team (MDT) reviews took 
place for patients admitted with Parkinson’s disease 
in 75/168 (44.6%) hospitals, with 32/73 reporting 
the presence of speech and language therapy, 28/73 
dietetics and 19/73 nutrition team members
40. 221/426 (51.9%) patients had their care reviewed at an 
MDT meeting during their admission
41. 158/246 (64.2%) patients had an appropriate MDT 
discussion undertaken during their admission in the 
opinion of the case reviewers
6MULTIDISCIPLINARY TEAM INVOLVEMENT DURING THE ADMISSION
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Texture modified meals may be provided to people who 
have chewing and swallowing difficulties, such as those 
with dysphagia. Food texture may be altered to reduce 
the likelihood of aspiration or choking. Equally, texture 
modification might enhance comfort and modified 
consistencies may help the patient to eat sufficient food 
to reduce the risk of malnutrition. There are international 
standards for the modification of food consistency set by 
the International Dysphagia Diet Standardisation Initiative 
(IDDSI) (see Appendix 2).22
Modified texture diet (food)
Data from the clinician questionnaire highlighted that a 
modified texture diet was indicated at some point during 
the admission for 108/462 (23.4%) patients. Where it was 
indicated, a modified texture diet was provided for all 103 
patients, where the data were available (there were five 
patients where this was unknown). In the opinion of the case 
reviewers, 101/314 (32.2%) patients required a modified 
texture diet while they were an inpatient (Table 7.1). 
There was evidence in the case notes that a modified 
texture diet was advised for 95/278 (34.2%) patients, and 
in the majority (80/95) this was advised by the speech and 
language therapy (SLT) team (Table 7.2). Where a modified 
texture diet was advised, there was evidence in the case 
notes that this was provided for 72/88 patients, and that 
dietary instructions were followed for 61/66 patients, where 
the data were available. 
Texture modifications (food and drink)
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A 59-year-old patient was admitted with cellulitis 
involving a superficial leg wound requiring intravenous 
antibiotics. The patient’s dysphagia was noted on 
admission. On the morning of the admission the patient 
was assessed by the speech and language team and 
then received regular reassessments until discharge. 
The reviewers commented on the excellence of the 
speech and language input and the documented 
involvement of other healthcare professionals, all 
coordinated by the admitting medical team.
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Clinician questionnaire and case reviewer data
Table 7.1 A modified texture diet was indicated at 
some point during the admission
Clinician view Case reviewer 
view
 Number of 
patients
% Number of 
patients
%
Yes 108 23.4 101 32.2
No 354 76.6 213 67.8
Subtotal 462  314  
Unknown 43  30  
Total 505  344  
Table 7.2 Evidence in the case notes that a modified 
texture diet was advised
 Number of 
patients
%
Yes – by speech and language 
therapy
80 28.8
Yes – by someone else 15 5.4
No 183 65.8
Subtotal 278  
NA 60  
Unable to answer 6  
Total 344  
Case reviewer data
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A multidisciplinary approach to meal planning, to ensure 
the menu was nutritionally analysed and compliant with 
modified texture meals, was present in 100/138 (72.5%) 
hospitals. Where this occurred, dietitians were involved 
in 100/100 (100.0%) hospitals; SLTs in 97/100 (97.0%) 
hospitals and catering in 86/100 (86.0%) hospitals (data 
not shown). 
Thickened fluids
Thin liquids, such as water, pose safety challenges for 
patients with dysphagia because they flow too quickly. 
Therefore, thickened liquids are frequently recommended 
with the goal of slowing down the flow to allow more 
time for airway closure. Thickened liquids can also increase 
sensory awareness/feedback which may contribute to 
improvements in swallow function. 
Data from the clinician questionnaire reported that 
thickened fluids were indicated at some point during the 
admission for 80/464 (17.2%) patients. From this group, 
the clinician completing the questionnaire reported that 
52/68 patients, where it could be assessed, had indicators 
of dysphagia during the admission. Thickened fluids were 
used for 71/76 patients (Table 7.3). This was communicated 
to pharmacy for 52/53 patients and was unknown for 
an additional 18 patients. Medication was modified 
appropriately for 64/66 patients. 
The case reviewers considered there was evidence in the 
notes that a thickener was advised for 59/268 (22.0%) 
patients (Table 7.4). Where a thickener was advised, there 
was evidence in the notes that catering/housekeeping 
were notified in only 17/44 instances, and this was 
communicated to pharmacy in 17/45 instances. There was 
evidence in the case notes that thickener was provided to 
40/50 patients, and medication was modified appropriately 
for 25/36 of these patients. 
A hospital policy for the prescribing and use of thickeners 
was in place in 99/148 (66.9%) hospitals.
In 101/135 (74.8%) hospitals the thickeners used in hospital 
were the same as those used in the community. 
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Clinician questionnaire data
Table 7.3 Thickened fluids were indicated at some point during the admission
 Thickener indicated Thickener advised Thickener used
Number of patients % Number of patients Number of patients
Yes 80 17.2 72 71
No 384 82.8 6 5
Subtotal 464  78 76
Unknown 41  2 4
Total 505  80 80
Table 7.4 Evidence in the case notes that a thickener 
was advised for addition to fluids
 Number of 
patients
%
Yes – by speech and language 
therapy
50 18.7
Yes – by someone else 9 3.4
No 209 78.0
Subtotal 268  
NA 70  
Unable to answer 6  
Total 344  
Case reviewer data
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42. 101/314 (32.2%) patients required a modified texture 
diet whilst they were an inpatient in the opinion of the 
case reviewers
43. There was evidence in the case notes that a modified 
texture diet was advised for 95/278 (34.2%) patients; in 
80/95 patients this was advised by speech and language 
therapy 
44. Where advised, a modified texture diet was provided for 
72/88 patients 
45. 100/138 (72.5%) hospitals had a multidisciplinary 
approach to meal planning 
46. Where a thickener was advised, there was evidence in 
the notes that catering/housekeeping were notified in 
only 17/44 instances, and this was communicated to 
pharmacy in 17/45 instances
47. An organisational policy for the prescribing and use of 
thickeners was in place in 99/148 (66.9%) hospitals  
7TEXTURE MODIFICATIONS (FOOD AND DRINK)
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Medication at arrival and admission was covered in 
Chapter 4 where it was noted that complications can 
develop if medication for Parkinson’s disease (PD), 
particularly levodopa, is not taken on time, or medications 
are not provided via a suitable route. Options that have 
been suggested for taking medication include:23
•	 “Whole	tablets	or	capsules,	crushed	tablets	or	
opened capsules taken with a spoonful of food at the 
appropriate IDDSI Level for the patient. This is likely to 
be the best option for most patients
•	 Whole	tablets	or	capsules,	crushed	tablets	or	opened	
capsules taken with a spoonful of thickened fluid at the 
appropriate IDDSI Level for the patient
•	 Liquid	medicine	mixed	with	a	thickening	agent”
Missed medications
Medication was missed during the admission for 121/416 
(29.1%) patients (Table 8.1) and was more likely to be missed 
in patients with dysphagia (dysphagia 45/76; 59.2%; no 
dysphagia 54/271; 19.9%) The principal reasons for missing 
medication were as a result of the patient being made ‘nil 
by mouth’ (33/110; 30.0%), the patient being unable to 
take the medication (32/110; 29.1%) or the patient refusing 
medication (22/110; 20.0%) (Table 8.2) overleaf. Of the 22 
patients where refusal was given as a reason for missing their 
medication, 11 had dementia listed as a comorbidity.
Medication management during the admission
8
Clinician questionnaire data
Table 8.1 Medication was missed during the patient’s admission by presence of dysphagia





% Number of 
patients






Yes – once 13 17.1 26 9.6 39 11 50
Yes – more than once 32 42.1 28 10.3 60 11 71
No 31 40.8 217 80.1 248 47 295
Subtotal 76  271  347 69 416
Unknown 7  58  65 24 89
Total 83  329  412 93 505
A 76-year-old patient was found collapsed at home 
and brought into the emergency department (ED) by 
ambulance. In the ED the staff found medication for 
the patient’s Parkinson’s disease (PD) in their personal 
effects. The PD team were called to the ED to advise 
on the patient’s medication. The patient was admitted 
with a urinary tract infection and while an inpatient was 
seen regularly by the PD team and speech and language 
therapy (SLT). 
 
The reviewers commented on the promptness of both 
the PD team involvement and SLT. They remarked that 
this demonstrated good practice in minimising delays in 
patients receiving PD medication.
C A S E   S T U D Y   6
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Availability of medicines
A policy for the administration of medication to patients 
who have dysphagia or who develop it in hospital was in 
place in 113/156 (72.4%) hospitals. Where this policy was 
in place, this complied with the Parkinson’s UK Medicines 
Optimisation Consensus Statement8 in 75/81 hospitals 
(there were a further 32 hospitals where this was unknown).
Access to medication should be maintained and medication 
for PD should be on the critical medicines list so that 
supplies can be accessed at all times.8,24 Data from 
the organisational questionnaire indicated there were 
differences in the medications available in different ward 
areas in 94/141 (66.7%) hospitals.
Data from the clinician questionnaire indicated that, on 
admission, there was no check for 96/257 (37.4%) 
patients that their last scheduled dose of PD medication 
had been taken.
Changes to medication 
Medication for PD was altered during the admission for 
114/458 (24.9%) patients. This was more likely to occur in 
patients who experienced dysphagia during the admission 
(dysphagia 46/81; 56.8% vs. no dysphagia 46/302; 15.2%). 
The main reason for medication to be altered was as a result 
of swallowing difficulties (46/111; 41.4%) (Table 8.3).
Management of medications 
There was evidence in the case notes that medicines 
management was appropriately undertaken for 210/263 
(79.8%) patients. Where medications management was 
not appropriately undertaken, case reviewers thought this 
affected the outcome for 12/39 patients.
Table 8.2 The reasons for medications being missed
 Number of 
patients
%
Patient ‘nil by mouth’ 33 30.0
Patient unable to take 32 29.1
Patient refused 22 20.0
Not available on the ward 18 16.4
Awaiting medication review 10 9.1
Not suitable medication for a 
feeding tube
6 5.5
Awaiting confirmation of feeding 
tube placement
5 4.5
Not available in the pharmacy 3 2.7
Patient away from the ward 3 2.7
Other 3 2.7
Subtotal 110  
Unknown 11  
Total 121  
Answers may be multiple; n=110
Organisational data 
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Table 8.3 The reason for the patient’s Parkinson’s 
disease medication to be altered
 Number of 
patients
%





Worsening of condition 24 21.6




Non-availability of medicines 0 0.0
Other 36 32.4
Subtotal 111  
Unknown 3  
Total 114  
Answers may be multiple; n=111
Clinician questionnaire data
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There was evidence in the case notes that the mode of 
provision of medication was considered if dysphagia was 
present for 82/166 (49.4%) patients (Table 8.4). The case 
reviewers also found evidence that the mode of provision 
of medication was determined for 71/107 (66.4%) patients 
who experienced dysphagia during the admission.
Delay in administration of medication
In the opinion of the case reviewers, there was a delay 
in the administration of medication following admission 
for 57/263 (21.7%) patients. The main reasons for delay 
were the absence of medications on the ward (13/52) or 
the patient was ‘nil by mouth’ (13/52) (Table 8.5). Where 
the reason was recorded ‘other’ the most common reason 
related to patient refusal (5/21); there were four instances 
where the reason for delay was not recorded in the case 
notes nor the medication chart returned. Delay occurred 
more frequently in patients identified by case reviewers as 
experiencing dysphagia during the admission (Table 8.6).
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Table 8.5 Reasons for the delay in administering 
medications
 Number of 
patients
%
Not available on the ward 13 13.3
Patient ‘nil by mouth’ 13 86.7
Patient unable to swallow 10  
Non-availability in the emergency 
department
5  
Non-availability in the pharmacy 1  
Other 19
Subtotal 52
Unable to answer 5
Total 57
Case reviewer data
Table 8.4 Evidence in the case notes that the 
method of provision of medication was considered 
if dysphagia was present





Subtotal 166  
NA 167  
Unable to answer 11  
Total 344  
Case reviewer data
Case reviewer data
Table 8.6 Delay in the administration of medication by presence of dysphagia during the admission 









% Number of 
patients 






Yes 28 28.6 22 16.2 50 7 57
No 75 76.5 114 83.8 189 17 206
Subtotal 98  136  234 24 258
Unable to answer 23  50  73 8 81
Total 126  186  312 32 344
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The presence of a PD team was associated with more 
frequent changes in the patient’s medication (Table 8.7). 
Rotigotine patches
While levodopa is considered the most effective drug for 
managing PD symptoms it may not always be possible for 
patients to take it orally. Rotigotine, another PD medication 
can be delivered via skin patches and a once-daily patch 
provides stable concentrations of the drug over 24 hours. 
This route of rotigotine delivery is useful in patients 
scheduled for surgery or in those with dysphagia. 
It is important to note that specialist advice should be 
sought before modifying any drug therapy.
A policy for the use of rotigotine patches in patients with PD 
was in place in 127/158 (80.4%) hospitals (Table 8.14). The 
presence of a policy was not affected by the presence of a 
specialist PD team.
Data from the clinician questionnaire showed that 88/468 
(18.8%) patients were prescribed a rotigotine patch while 
in hospital (Table 8.15). Where a rotigotine patch was 
prescribed, alternative forms of medication had been 
considered for 42/68 patients; the Parkinson’s UK Medicines 
Optimisation Consensus Statement8 consulted for 21/50 
patients, and there was a clear plan in place to review the 
patch before discharge for 44/75 patients. Clinicians were 
of the opinion that a patch should have been prescribed for 
only 37/69 patients (Table 8.8).



























Yes 42 21 44 37
No 26 29 31 32
Subtotal 68 50 75 69
Unknown 20 38 13 19
Total 88 88 88 88
Clinician questionnaire data
Table 8.7 Changes to the patient’s Parkinson’s disease medication by referral to the Parkinson’s disease team 
during the admission
 Parkinson’s disease medication changed during the admission











Yes 32 35 67 6 73
No 28 117 145 13 158
Subtotal 60 152 212 19 231
Not applicable 0 1 1 0 0
Unable to answer 6 6 12 0 12
Total 66 159 225 19 244
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Clinician questionnaire data and case reviewer data
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The case reviewers found evidence that the patient was 
prescribed a rotigotine patch while in hospital in 80/339 
(23.6%) sets of case notes. Where a patch had been 
prescribed, in the opinion of the case reviewers this was 
appropriate for 67/70 patients. There was evidence in the 
notes that there was a clear plan to review the patch prior 
to discharge in 25/45 patients. There was no evidence in the 
case notes that 38/72 patients who had a rotigotine patch 
prescribed were referred to the PD team during this admission. 
Medication at discharge
Data from the clinician questionnaire highlighted that 
information on the administration of medicines prior to 
discharge was provided to 168/292 (57.5%) patients/
carers and that information was more likely to be provided 
if the patients’ PD medication had been altered during the 
admission (Table 8.9). 
Almost all patients (431/442; 97.5%) had a discharge 
summary provided on discharge from hospital (see Chapter 
10). The discharge summary mentioned the administration 
of medication in 262/416 (63.0%) and information about 
the treatment period and frequencies in 190/416 (45.7%).
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An 82-year-old patient with Parkinson’s disease (PD) 
was admitted following a fall at home and sustaining 
a fractured neck of femur. Prior to surgery the patient 
remained ‘nil by mouth’ for a significant period of 
time, which led to them not receiving their normal PD 
medication. An anaesthetist liaised with the PD team 
who visited the patient and considered treatment 
options and prescribed a rotigotine patch. The patient 
had surgery to fix the fracture and, with continuing input 
from the PD team and speech and language therapy, 
returned to their care home 14 days post-operatively. 
The case reviewers recognised the importance of 
involvement of the PD team and the recognition of 
the need for an alternative route of administration. 
However, they commented on the extensive ‘nil by 
mouth’ period and the effect it had on the patient.
C A S E   S T U D Y   7
Clinician questionnaire data
Table 8.9 The patient/carer received information on the administration of medicines prior to discharge by 
Parkinson’s disease medication alterations
Was the patient’s PD medication altered during this admission?
Yes No Subtotal Unknown Total
Number of 
patients
% Number of 
patients






Yes 47 64.4 114 54.5 161 7 168
No 26 35.6 95 45.5 121 3 124
Subtotal 73 209 282 10 292
Unknown 41 135 176 37 213
Total 114 344 458 47 505
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48. 121/416 (29.1%) patients missed medication during 
their hospital stay. The principal reasons for this were the 
patient being ‘nil by mouth’ (33/110; (30.0%) and being 
unable to take the medication (32/110; 29.1%)
49. 113/156 (72.4%) hospitals reported a policy for the 
administration of medication to patients who have 
dysphagia or who develop it in hospital in place. Where 
this policy was in place, it complied with the Parkinson’s 
UK Medicines Optimisation Consensus Statement in 
75/81 hospitals
50. On admission, there was no check for 96/257 (37.4%) 
patients that their last scheduled dose of PD medication 
had been taken 
51. Where medication management was not appropriately 
undertaken, case reviewers thought this affected the 
outcome for 12/39 patients
52. 82/166 (49.4%) patients with dysphagia had their mode 
of provision of medication considered 
53. The mode of provision of medication was determined 
for 71/107 (66.4%) patients who experienced dysphagia 
during the admission in the opinion of the case 
reviewers
54. 127/158 (80.4%) hospitals had a policy for the use of 
rotigotine patches in patients with Parkinson’s disease 
55. 88/468 (18.8%) patients were prescribed a rotigotine 
patch while in hospital 
56. Where a rotigotine patch was prescribed, alternative 
forms of medication had been considered for 42/68 
patients; the Parkinson’s UK Medicines Optimisation 
Consensus Statement consulted for 21/50 patients, 
and there was a clear plan in place to review the patch 
before discharge for 44/75 patients
57. 168/292 (57.5%) patients/carers were provided with 
information on the administration of medicines prior 
to discharge. The information was more likely to be 
provided if the patient’s Parkinson’s disease medication 
had been altered during the admission 
Key Findings
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‘Risk feeding’
When swallowing difficulties (dysphagia) become severe, it is 
often considered unsafe for patients to continue eating and 
drinking due to the risk of aspiration and choking.4 The term 
‘risk feeding’ is used when a patient continues to eat and 
drink orally despite the associated risks. ‘Risk feeding’ may be 
deemed appropriate for a number of reasons:25
• Alternative	feeding	options	(via	a	feeding	tube)	may	not
be feasible due to the patient’s medical condition
• The	risks	of	alternative	feeding	options	may	be	too	high
• The	patient	may	be	at	the	end	of	their	life	and	a
palliative approach deemed more appropriate by the
patient, their family or the medical team
• Alternative	feeding	may	not	prolong	or	improve	the
patient’s quality of life
• An	informed	patient	who	retains	mental	capacity	may
not be prepared to give up the pleasure of eating
and drinking, nor may they wish to have an invasive
procedure such as insertion of a feeding tube.
The decision-making process around ‘risk feeding’ is 
complex and decisions should always be made and actioned 
following discussion with the patient, their family and the 
multidisciplinary team. If such a discussion does not take 
place it could lead to patients being kept ‘nil by mouth’, 
without an alternative means of feeding, to the detriment 
of their comfort and nutrition.25,26
Organisational data showed that 104/160 (65.0%) hospitals 
were reported as having a policy for ‘risk feeding’. The 
policy covered the interface between primary and secondary 
care in 60/78 hospitals. The policy met the Plain English 
standards recommended for patients27 in 42/45 hospitals 
and was unknown in a further 59/104 hospitals. 
The clinician questionnaire data showed that 38/421 (9.0%) 
patients were ‘risk feeding’ prior to admission to hospital. 
Of this group, 30/38 had a re-evaluation of ‘risk feeding’ on 
admission. Within the 383 patients not already ‘risk feeding’ 
at admission, a further 29 patients were considered for 
‘risk feeding’ on, or following, admission. Within this group, 
an assessment was undertaken prior to ‘risk feeding’ 
for 26/27 patients, and this included an assessment of 
mental capacity, to make the decision at the time, for 
17/22 patients. 
The reviewers found evidence in the case notes that ‘risk 
feeding’ was considered in 49/292 (16.8%) patients 
assessed. Speech and language therapists were involved in 
the discussions for 41/110 (37.3%) patients. ‘Risk feeding’ 
was subsequently undertaken in 36/46 patients (Table 9.1). 
Case reviewers indicated ‘risk feeding’ had been undertaken 




Table 9.1 Evidence of ‘risk feeding’ in the case notes
‘Risk feeding’ was considered Speech and language therapy 
involved in the discussion
‘Risk feeding’ 
undertaken
Number of patients % Number of patients % Number of patients
Yes 49 16.8 41 37.3 36
No 243 83.2 69 62.7 10
Subtotal 292 110 46
NA 47 219 -
Unable to answer 5 15 3
Total 344 344 49
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58. 104/160 (65.0%) hospitals were reported as having a 
policy for ‘risk feeding’ 
59. An assessment of mental capacity was undertaken 
in 17/22 patients who were being assessed for ‘risk 
feeding’ 
60. Speech and language therapists were involved in the 
discussions related to ‘risk feeding’ for 41/110 (37.3%) 





People with Parkinson’s disease (PD) and their family 
members should be offered the opportunity to develop 
an Advance Care Plan, by discussing the prognosis of the 
condition. This discussion should establish priorities centred 
around the patient’s wishes which are then recorded in the 
Advance Care Plan. The options considered might include 
‘Advance Decisions to Refuse Treatment’ (ADRT), ‘Do Not 
Attempt Cardiopulmonary Resuscitation (DNACPR) decision, 
‘Recommended Summary Plan for Emergency Care and 
Treatment’ (ReSPECT) process and lasting powers of attorney 
for finance and property and/or health and welfare. End 
of life care may also need to be considered. This is likely to 
be a difficult area to discuss but should not be ignored. All 
discussions are likely to be informed by the patient’s ability 
to make specific decisions, and this should be aided by 
mental capacity assessments specific to each decision.
Markers of advanced disease were present in 183/432 
(42.4%) patients and 52/383 (13.6%) patients had an 
Advance Care Plan or similar plan in place, which was 
more likely to be in place as the severity of the disease 
increased (Table 10.1).
Responses to the clinician questionnaire indicated end 
of life care was discussed with 114/472 (24.2%) patients 
during the admission. Most frequently this was with family 
members (95/110; 86.4%) and the patient (48/110; 43.6%) 
(Table 10.2). 
The reviewers reported that 61/340 (17.9%) patients were 
‘not for active treatment’ as they were nearing the end of 
their life. For the majority of these patients (49/59) the end 
of life care provided during the admission was assessed by 
the reviewers to be satisfactory.
















Other family members 95 86.4
Patient 48 43.6
Carers 10 9.1
Usual Parkinson’s disease specialist 5 4.5
GP 3 2.7





Answers may be multiple; n=110
Advance care planning, palliative and end of life care
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Discharge planning should start as early as possible during 
a hospital admission. For people with Parkinson’s disease 
(PD), plans for discharge should be co-ordinated across the 
different groups of professionals who are involved in their 
care during the hospital admission and their ongoing care in 
the community. 
It is well-established practice that the patient’s GP or 
community clinical team should receive a written discharge 
letter.27 The letter should also meet the standards for 
outpatient letters set by the Professional Record Standards 
Body.28






and any other professional groups.
In the context of patients with PD, any change in medication 
and/or specific dietary modifications should also be 
communicated to the patient’s GP.8 Consideration should 
also be given to the role community pharmacists play in the 
care of patients with PD.
Discharge process
The majority of patients (454/502; 90.4%) were discharged 
alive from this admission.
At discharge, the clinicians caring for the patient in hospital 
involved the home carers of 211/267 (79.0%) patients in 
discharge planning for (Table 11.1).
Case reviewers found evidence of the patient being 
referred to colleagues in the community, in 209/281 
(74.4%) sets of case notes. There was no evidence in the 
case notes of communication at discharge with those 
caring for the patient in the community in 90/275 (32.7%) 
cases reviewed. 
Risk assessment 
Data from the organisational questionnaire showed that 
patients with PD were routinely assessed for their level of 
risk of dysphagia in the community prior to discharge in 
108/148 (73.0%) hospitals. 
There was evidence in the case notes that the patient’s 
level of swallowing/aspiration risk in the community was 
considered prior to discharge for 61/210 (29.0%) patients. 
This was more likely to be considered where dysphagia was 
present during the admission (Table 11.2 overleaf). Where it 
was considered, an action plan was put into place for 52/60 
patients assessed, and this was considered to be adequate 
by the case reviewers in 49/51 instances.
Care at the point of discharge from hospital
11
Table 11.1 The patient’s home carers were involved 
in discharge planning





Subtotal 267  
Unknown 76  
Not applicable 111  
Total 454  
Clinician questionnaire data
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Prescription of thickened fluids
Thickened fluids were prescribed to 37/336 (11.0%) 
patients at discharge. Where the patient was prescribed 
thickeners, the discharge was considered to be inadequate 
for 13/23 patients and in 17/37  cases the patient and/or 
carer did not receive a copy of the discharge summary. The 
patient’s home carers were involved in discharge planning 
for 21/25 patients who were prescribed thickened fluids. 
Where thickened fluids were indicated at some point 
during the admission 35/53 patients were prescribed 
thickeners at discharge.
Discharge summary
Almost all patients (431/442; 97.5%) had a written 
discharge summary on leaving hospital. Most commonly 
this included information about implemented interventions 
(294/416; 70.7%), the administration of medication 
(262/416; 63.0%) and information about the treatment 
period and frequencies (190/416; 45.7%) (Figure 11.1). 
11CARE AT THE POINT OF DISCHARGE FROM HOSPITAL
Case reviewer data
Table 11.2 Evidence in the case notes that the patient’s level of swallowing/aspiration risk in the community was 
considered prior to discharge by presence of dysphagia.









% Number of 
patients 






Yes 52 61.2 7 7.1 59 2 61
No 33 38.8 92 92.9 125 24 149
Subtotal 85  99  184 26 210
Unable to answer 3  7  10 2 12
NA 5  70  75 1 76
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Where a modified texture diet or fluids had been 
indicated during the admission, information on dietary 
recommendations was not included in the discharge 
summary for 52/88 patients. There was also variation in who 
received a copy of the discharge summary; most commonly 
this was the GP (422/425; 99.3%) and the patient and 
carers (208/425; 48.9%). The community-based team 
only received a copy for 28/425 (6.6%) patients, and the 
community pharmacist for 5/425 (1.2%) patients. Where 
the patient experienced dysphagia during the admission, 
the community team was given a copy of the discharge 
summary for 6/56 patients.
A discharge summary was available in 237/296 (80.1%) sets 
of case notes reviewed. Where a summary was provided, 
in the opinion of the case reviewers this was adequate in 
175/236 (74.2%) cases assessed.
The areas in which the summary was not considered 
adequate included documentation of medication 
management (9/61), documentation of allied health 
professional (AHP) involvement (9/61), documentation of 
advance care planning (8/61) and documentation of dietary 
advice (7/61).
Death
Responses to the clinician questionnaire indicated that 
23/48 patients who died experienced dysphagia during the 
admission (Table 11.3). The most common primary causes 
of death were bronchopneumonia/pneumonia (15/48) and 
aspiration pneumonia (10/48). 
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Clinician questionnaire data
Table 11.3 Outcome by presence of dysphagia






% Number of 
patients






Discharged alive 60 72.3 317 96.6 377 77 454
Died 23 27.7 11 3.4 34 14 48
Subtotal 83  328  411 91 502
Unknown 0  1  1 2 3
Total 83  329  412 93 505
61. At discharge, the clinicians caring for the patient in 
hospital involved the home carers in discharge planning 
for 211/267 (79.0%) patients 
62. There was no evidence in the case notes of 
communication at discharge with those responsible 
for the care of the patient in the community in 90/275 
(32.7%) cases reviewed 
63. There was evidence in the case notes that the patient’s 
level of swallowing/aspiration risk in the community was 
considered prior to discharge for 61/210 (29.0%) patients 
64. There was variation in who received a copy of the 
discharge summary; most commonly this was the GP 
(422/425; 99.3%) and the patient and carers (208/425; 
48.9%). The community-based team only received a 
copy for 28/425 (6.6%) patients, and the community 
pharmacist for 5/425 (1.2%) patients
65. Where a summary was provided, in the opinion of the 




Overall assessment of dysphagia care during 
the admission
The case reviewers assessed the overall dysphagia care the 
patient received during the admission. This was assessed to be 
good for 48/116 (41.4%) patients, adequate for 40/116 (34.5%) 
patients, and either poor or unsatisfactory for 28/116 (24.1%) 
patients (Figure 12.1). There were a further seven cases reviewed 
where dysphagia had been unrecognised as a symptom during 
the admission, and three cases where the reviewer was unable 
to grade the quality of dysphagia care provided.
Overall quality of care
The case reviewers were also asked to grade the overall 
quality of care the patient received during the admission. 
They considered this to be good for 159/336 (47.3%) 
patients. There was room for improvement for clinical 
care for 105/336 (31.3%) patients, in organisational 
care for 15/336 (4.5%) patients, and in clinical and 
organisational care for 48/336 (14.3%) patients. Care 
was graded to be less than satisfactory for 9/336 (2.7%) 
patients (Figure 12.2). 
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Presence of dysphagia and assessment of care
The overall quality of care was also analysed by the presence 
of dysphagia during the admission. The data seemed 
to describe that patients with dysphagia were less likely 
to experience good care than those without dysphagia 
(dysphagia 49/124; 39.5% vs. no dysphagia 106/182; 
58.2%) (Figure 12.3). However, these data should be 
considered with caution as the numbers are low.
66. Dysphagia care was graded as good for 48/116 (41.4%) 
patients and adequate for 40/116 (34.5%) patients
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Dysphagia (n=124)        No dysphagia (n=182)
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Advance Care Plan An opportunity for people to be involved in planning their future care, 
including medical treatment, while they have the capacity to do so
Advance Decisions to 
Refuse Treatment
ADRT This lets a person, while they have mental capacity, to choose and 
explain which medical treatments they do not want doctors to give 
them, if a time comes when they lack capacity and cannot make the 
decision or communicate their wishes
Do not attempt 
cardiopulmonary 
resuscitation
DNACPR A decision made by a person and/or their healthcare team not to 
attempt to restart their heart if the heart or breathing stops
Dysphagia This is the medical term for swallowing difficulties. Some people with 
dysphagia have problems swallowing certain foods or liquids, while 
others can't swallow at all.
Fibreoptic endoscopic 
evaluation of swallowing
FEES This a procedure in which a fibreoptic endoscope is inserted through 
the nose and into the throat to obtain a direct view of what happens 
when someone swallows
Impulse control disorder This is a condition in which a person has trouble controlling emotions 
or behaviours




MUST This is a five-step screening tool to identify adults, who are 
malnourished, at risk of malnutrition (undernutrition), or obese. It 
also includes management guidelines which can be used to develop a 
care plan. It is for use in hospitals, community and other care settings 
and can be used by all care workers.
Modified texture diet E.g. minced, chopped or pureed food
Nasogastric tube NG This is a thin tube passed into the stomach via the nose. It is used for 
short- or medium-term nutritional support
Nasojejunal tube NJ This is a thin tube passed into the small intestine, through into the 
stomach via the nose. It is used for short- or medium-term nutritional 
support
Orthostatic hypotension This is a sudden drop in blood pressure when someone stands from a 
seated or lying down position
Parkinson’s disease PD This is a brain disorder that leads to shaking, stiffness, and difficulty 
with walking, balance, and coordination. Parkinson's symptoms 
usually begin gradually and get worse over time. As the disease 




Parkinsonism This relates to any condition that causes a combination of the 
movement abnormalities seen in Parkinson's disease — such as 
tremor, slow movement, impaired speech or muscle stiffness 
Postencephalitic 
parkinsonism
This is a disease believed to be caused by a viral illness causing 
changes in the brain
Recommended summary 
plan for emergency care 
and treatment
ReSPECT This is a process that creates personalised recommendations for a 
person’s clinical care and treatment in a future emergency in which 
they are unable to make or express choices
Risk feeding This is when a person continues to eat and drink despite a significant 
risk of aspiration and or choking. This option is often appropriate 
when ensuring quality of life is the highest priority. It allows 
continued enjoyment, comfort, pleasure and social interaction 
associated with eating and drinking
Rotigotine This medication is given using skin patches to treat the signs and 
symptoms of Parkinson's disease 
Thickened fluids Thicker liquids may help people with dysphagia to improve the 
control of the movement of a food bolus
Urosepsis This is a type of sepsis that is caused by an infection in the urinary 
tract. It is a complication often caused by urinary tract infections that 
are not treated quickly or properly
Vascular parkinsonism This affects people with restricted blood supply to the brain.
Videofluoroscopic 
swallowing study
VFSS This is also known as modified barium swallow, is a radiographic 
procedure that provides a direct, dynamic view of someone 
swallowing
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Appendix 1: Line of sight between the 
recommendations, key findings and existing 
supporting evidence
Appendices 
Suggested groups to action the recommendation 
are shown in italics after each one, this is a guide 
only, not exhaustive. 
The term ‘healthcare professionals’ includes all 
specialties and grades who would be involved in 
the care of this group of patients
# represents the number of the supporting 
key finding
Associated guidelines 
and other related 
evidence
1 Document the swallow status of all patients 
with Parkinson’s disease at the point of referral 
to hospital.
Document the swallow status of all 
patients with Parkinson’s disease at the 
point of referral to hospital.
CHAPTER 2: PAGE 17
#3. 12/25 respondents to the online survey indicated 
that problems with eating, drinking or swallowing 
medication while in hospital were not taken seriously by 
the healthcare team
CHAPTER 3: PAGE 20
#6. 83/277 (30%) patients had dysphagia when 
presenting to hospital documented in the case notes
CHAPTER 4: PAGE 25
#10. 20/79 sets of notes of patients who were known 
to have dysphagia at the time of arrival did not contain 
information relating to dysphagia
NICE QS 164
2 Notify the specialist Parkinson’s disease service 
(hospital and/or community) when a patient 
with Parkinson’s disease is admitted, if there 
is any indication from the notes, or following 
discussion with the patient or their relatives/
carers, that there has been a deterioration or 
progression of their clinical state.
Target audiences: Healthcare professionals 
who see patients at admission, clinical and 
medical directors
CHAPTER 3: PAGE 22
#7. 307/397 (77.3%) patients were under the care of 
a Parkinson’s disease service prior to their admission
#8.180/316 (57%) sets of case notes contained no 
evidence that patients with Parkinson’s disease had a 
named contact with their Parkinson’s disease service
CHAPTER 6: PAGE 36
#32. Parkinson’s disease consultants and/or specialist 
nurses were involved for 160/497 (32.2%) patients
NICE QS 164  
NICE GUIDELINE 71
3 Screen patients with Parkinson’s disease for 
swallowing difficulties at admission, irrespective 





Target audiences: Healthcare professionals 
who see patients at admission and clinical 
directors
CHAPTER 3: PAGE 24
#9. 30/409 (7.3%) patients had a history of aspiration 
pneumonia prior to their index admission. Of these 
30 patients, 18/24 patients had dysphagia. Of those 






CHAPTER 4: PAGE 26
#11. An assessment of whether the patient had 
symptoms of dysphagia was made for 179/479 (37.4%) 
patients
#12. 287/479 (59.9%) patients had their ability to 
continue with normal diet and fluid intake, which is an 
indicator of dysphagia, assessed at admission. Similarly, 
assessment of dehydration and difficulty in controlling 
saliva, were assessed in 222/479 (46.3%) and 62/479 
(12.9%) patients respectively
#13. 123/312 (39.4%) patients had documented 
assessments of dysphagia at the initial assessment, while 
a similar number of patients (133/335; 39.7%) reported 
difficulty with speech
CHAPTER 4: PAGE 27
#14. 44/316 (13.9%) patients had swallow screening 
undertaken within 4 hours of arrival. This missed 51/75 
patients who were known to have dysphagia on arrival
CHAPTER 4: PAGE 28
#16. 96/449 (21.4%) patients had indicators of 
dysphagia on admission. The most common indicators 
were difficult or slow chewing and swallowing and 
coughing or choking 
CHAPTER 5: PAGE 34
#22. 88/161 (54.7%) hospitals had a protocol for the 
screening of dysphagia, and 105/163 (64.4%) had a 
protocol for the assessment of dysphagia
#23. 117/457 (25.6%) patients had a formal 
assessment of swallowing undertaken during the 
admission as recorded in the clinician questionnaire
#24. There was evidence in the notes that a formal 
assessment of swallowing was undertaken during the 
admission for 100/335 (29.9%) patients. Where such an 
assessment was not undertaken the case reviewers were 
of the opinion that one should have been undertaken 
for a further 51/200 (25.5%) patients
#26. Case reviewers indicated the presence of 
dysphagia was not assessed adequately during the 
hospital admission for 93/218 (42.7%) patients
CHAPTER 5: PAGE 35
#27. Case reviewers found that there was a delay in 
recognising dysphagia in 23/114 (20.2%) of patients 
while they were in hospital
#28. Where there was a delay in recognising dysphagia, 
case reviewers were of the opinion that this affected the 
outcome for 6/18 patients
CHAPTER 12: PAGE 62
#66. Dysphagia care was graded as good for 48/116 




4 Refer patients with Parkinson’s disease who have 
swallowing difficulties* (or who have problems 
with communication) to speech and language 
therapy. 
Target audiences: Healthcare professionals 
who see patients throughout their 
admission and clinical directors
*See Figure 4.3 in the report for a list of
indicators of swallowing difficulties
CHAPTER 4: PAGE 26
#11. An assessment of whether the patient had 
symptoms of dysphagia was made for 179/479 (37.4%) 
patients
CHAPTER 4: PAGE 28
#15. 51/209 (24.4%) patients were referred to speech 
and language therapy following swallow screening 
on arrival at hospital. The case reviewers were of the 
opinion that a further 36/132 (27.3%) patients should 
have been referred
#16. 96/449 (21.4%) patients had indicators of 
dysphagia on admission. The most common indicators 
were difficult or slow chewing and swallowing and 
coughing or choking 
CHAPTER 4: PAGE 30
#17. 96/377 (25.5%) patients were referred to speech 
and language therapy on admission, and in 87 patients 
this was for dysphagia
CHAPTER 6: PAGE 39
#34. The reviewers were of the opinion that a further 
46/187 (24.6%) patients should have been referred 
to speech and language therapy and 67/195 (34.4%) 
patients to the Parkinson’s disease team
CHAPTER 6: PAGE 41
#36. Where patients were referred, case reviewers 
indicated there was a delay in referral to speech and 
language therapy in 25/96 patients and delay in referral 
to dietetics in 16/64 patients
NICE QS 164  
NICE GUIDELINE 71
5 Ensure patients are able to take the medication 
they have been prescribed at, and throughout, 
their admission. If there are concerns about 
whether or not the patient can swallow safely 
consider other formulations of medication 
(e.g. liquid rather than a tablet) or ways of 
administering them. 
Target audiences: Healthcare professionals 
who see patients at, and throughout, 
their admission, pharmacists, and clinical 
directors
NB: Levodopa should be administered within 
30 minutes of the prescribed administration 
time. This is in line with NICE Quality Standard 
164. See also the Parkinson’s UK medication 
optimisation consensus statement 
CHAPTER 4: PAGE 31
#18. 81/283 (28.6%) patients admitted via the 
emergency department missed one or more doses of 
medication. For a further 158/505 (31.3%) patients it 
was unclear whether they had missed a dose. Of the 
114 responses recorded as to why medication was not 
given, 21/114 (18.4%) were due to a clinical suspicion 
of dysphagia and 20/114 (17.5%) were due to a 
decision to keep the patient ‘nil by mouth’ 
CHAPTER 8: PAGE 50
#48. 121/416 (29.1%) patients missed medication 
during their hospital stay. The principal reasons for this 
were the patient being ‘nil by mouth’ (33/110; (30.0%) 
and being unable to take the medication (32/110; 
29.1%)
CHAPTER 8: PAGE 51
#49. 113/156 (72.4%) hospitals reported a policy for 
the administration of medication to patients who have 
dysphagia or who develop it in hospital in place. Where 
this policy was in place, it complied with the Parkinson’s 
UK Medicines Optimisation Consensus Statement in 
75/81 hospitals
#50. On admission, there was no check for 96/257 
(37.4%) patients that their last scheduled dose of PD 
medication had been taken 












6 Ensure there is a hospital policy for the different 
ways of administering medication and the review 
of medications at the point of patient discharge. 
This includes the use of rotigotine patches.
Target audiences: Clinical directors, 
medical directors, hospital pharmacists, 
specialist Parkinson’s disease teams and 
quality improvement leads
CHAPTER 8: PAGE 53
#54. 127/158 (80.4%) hospitals had a policy for the use 
of rotigotine patches in patients with Parkinson’s disease
#55. 88/468 (18.8%) patients were prescribed a 
rotigotine patch while in hospital
#56. Where a rotigotine patch was prescribed, 
alternative forms of medication had been considered 
for 42/68 patients; the Parkinson’s UK Medicines 
Optimisation Consensus Statement consulted for 21/50 
patients, and there was a clear plan in place to review 






7 Screen the nutritional status of patients admitted 
to hospital with Parkinson’s disease and act on 
the findings. 
Target audiences: Clinical directors, 
dietitians, nutrition team members and 
healthcare professionals who see patients 
at, and throughout, their admission
NB: All patients admitted to hospital should 
undergo a nutritional screen using a validated 
screening tool such as the BAPEN Malnutrition 
Universal Screening Tool (MUST) this in line with 
NICE Quality Standard 24 
CHAPTER 4: PAGE 32
#19. 69/152 (45.4%) hospitals did not have a policy 
for the nutritional assessment of patients admitted with 
Parkinson’s disease
#20. 295/434 (68.0%) patients had a nutrition screen 
undertaken on admission as recorded in the clinician 
questionnaire. This was documented in the case notes 
of 162/336 (48.2%) patients
#21. There was evidence in the case notes that a 
Malnutrition Universal Screening Tool (MUST) score was 




8 Involve speech and language therapists, 
pharmacists, dietitians and nutrition team 
members in any multidisciplinary (MDT) 
discussion of patients with Parkinson’s disease 
and swallowing difficulties.   
Target audiences: Clinical directors, speech 
and language therapists, pharmacists, 
dietitians and nutrition team members
CHAPTER 6: PAGE 39
#34. The reviewers were of the opinion that a further 
46/187 (24.6%) patients should have been referred 
to speech and language therapy and 67/195 (34.4%) 
patients to the Parkinson’s disease team
CHAPTER 6: PAGE 41
#36. Where patients were referred, case reviewers 
indicated there was a delay in referral to speech and 
language therapy in 25/96 patients and delay in referral 
to dietetics in 16/64 patients
CHAPTER 6: PAGE 44
#39. Specialist multidisciplinary team (MDT) reviews 
took place for patients admitted with Parkinson’s 
disease in 75/168 (44.6%) hospitals, with 32/73 
reporting the presence of speech and language therapy, 
28/73 dietetics and 19/73 nutrition team members
#40. 221/426 (51.9%) patients had their care reviewed 
at an MDT meeting during their admission
CHAPTER 6: PAGE 45
#41. 158/246 (64.2%) patients had an appropriate 
MDT discussion undertaken during their admission in 
the opinion of the case reviewers




9 Formalise pathways for the provision of modified 






This is in line with the International Dysphagia 
Diet Standardisation Initiative (IDDSI)
Target audiences: Medical directors, clinical 
directors, clinical teams caring for patients 
with dysphagia. This includes speech and 
language therapists, pharmacists, dietitians, 
hospital housekeeping and catering 
services, community Parkinson’s disease 
teams and quality improvement leads
CHAPTER 4: PAGE 32
#19. 69/152 (45.4%) hospitals did not have a policy 
for the nutritional assessment of patients admitted with 
Parkinson’s disease
CHAPTER 7: PAGE 47
#42. 101/314 (32.2%) patients required a modified 
texture diet whilst they were an inpatient in the opinion 
of the case reviewers
#43. Where was evidence in the case notes that a 
modified texture diet was advised for 95/278 (34.2%) 
patients; in 80/95 patients this was advised by speech 
and language therapy
CHAPTER 7: PAGE 48
#45. 100/138 (72.5%) hospitals had a multidisciplinary 
approach to meal planning
#46. Where a thickener was advised, there was evidence 
in the notes that catering/housekeeping were notified 
in only 17/44 instances, and this was communicated to 
pharmacy in 17/45 instances
#47.  A hospital policy for the prescribing and use of 
thickeners was in place in 99/148 (66.9%) hospitals
International Dysphagia Diet 
Standardisation Initiative 
(IDDSI)
10 Ensure there is a hospital policy for ‘risk feeding’ 
which includes the assessment or re-assessment 
(if already undertaken at admission) of mental 
capacity regarding this decision. The policy 






Target audiences: Clinical directors, 
medical directors, speech and language 
therapists, pharmacists, dietitians and 
nutrition team members and quality 
improvement leads
CHAPTER 9: PAGE 56
#58. 104/160 (65.0%) hospitals were reported as 
having a policy for ‘risk feeding’
#59. The assessment of mental capacity undertaken 
in 17/22 patients who were being assessed for ‘risk 
feeding’
#60. Speech and language therapists were involved 
in the discussions related to ‘risk feeding’ for 41/110 
(37.3%) patients. ‘Risk feeding’ was subsequently 
undertaken in 36/46 patients
73
APPENDICES
11 Provide written information at discharge on how 




ways of administering them
• Nutrition	screening	tool	score	and	care	plan








GP, community Parkinson’s disease team,
community pharmacist, care home staff)
A proforma could be used for this discharge 
summary. 
Target audiences: Clinical directors, 
healthcare professionals who see patients 
throughout their admission, quality 
improvement leads
CHAPTER 2: PAGE 17
#2. 11 patient/carer respondents to the online survey 
reported that food, drink or medication was given while 
the patient was lying down
CHAPTER 8: PAGE 54
#57. 168/292 (57.5%) patients/carers were provided 
with information on the administration of medicines 
prior to discharge. The information was more likely to be 
provided if the patient’s Parkinson’s disease medication 
had been altered during the admission 
CHAPTER 11: PAGE 59
#61. At discharge, the clinicians caring for the patient 
in hospital involved the home carers in discharge 
planning for 211/267 (79.0%) patients
#62. There was no evidence in the case notes of 
communication at discharge with those responsible 
for the care of the patient in the community in 90/275 
(32.7%) cases reviewed
#63. There was evidence in the case notes that the 
patient’s level of swallowing/aspiration risk in the 
community was considered prior to discharge for 
61/210 (29.0%) patients
CHAPTER 11: PAGE 61
#64. There was variation in who received a copy of the 
discharge summary; most commonly this was the GP 
(422/425; 99.3%) and the patient and carers (208/425; 
48.9%). The community-based team only received a 
copy for 28/425 (6.6%) patients, and the community 
pharmacist for 5/425 (1.2%) patients
#65. Where a summary was provided, in the opinion 




Appendix 2: Useful links 
PARKINSON’S UK
https://www.parkinsons.org.uk/
PARKINSON’S UK HELPLINE 0808 800 0303
The Parkinson’s UK helpline is a free and confidential service providing support to anyone affected by Parkinson’s.
hello@parkinsons.org.uk
Emails answered within 5 working days.
Text relay: 18001 0808 800 0303
Textphone number for textphone users only.
APPENDICES
Stage Hoehn and Yahr Scale Modified Hoehn and Yahr Scale
1 Unilateral involvement only usually with minimal 
or no functional disability
Unilateral involvement only
1.5 - Unilateral and axial involvement
2 Bilateral or midline involvement without 
impairment of balance
Bilateral involvement without impairment of balance
2.5 - Mild bilateral disease with recovery on pull test
3 Bilateral disease: mild to moderate disability 
with impaired postural reflexes; physically 
independent
Mild to moderate bilateral disease; some postural instability; 
physically independent
4 Severely disabling disease; still able to walk or 
stand unassisted
Severe disability; still able to walk or stand unassisted
5 Confinement to bed or wheelchair unless aided Wheelchair bound or bedridden unless aided
Stage
Early or diagnosis stage The time when someone is first experiencing symptoms, 
being diagnosed and then coming to terms with this
Maintenance stage When symptoms are controlled, perhaps by medication
Advanced stage Often called the 'complex phase'
Palliative stage Providing relief from the symptoms, stress and pain of the 
condition
HOEHN and YAHR SCALE
STAGES OF PARKINSON’S DISEASE
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427– 442
MacMahon DG and Thomas S. (1998). Practical approach to quality of life in Parkinson’s disease: the nurse’s role. J Neurol. 1998 May;245 
Suppl 1:S19-22 (doi: 10.1007/pl00007732)
75
MOVEMENT DISORDER SOCIETY - UNIFIED PARKINSON’S DISEASE RATING SCALE 
(MDS-UPDRS)
https://www.movementdisorders.org/MDS/MDS-Rating-Scales/MDS-Unified-Parkinsons-Disease-Rating-Scale-MDS-UPDRS.htm
INTERNATIONAL DYSPHAGIA DIET STANDARDISATION INITIATIVE (IDDSI) 
FRAMEWORK
https://iddsi.org/IDDSI/media/images/Complete_IDDSI_Framework_Final_31July2019.pdf (https://iddsi.org/)
© The International Dysphagia Diet Standardisation Initiative 2019 
@ https://iddsi.org/framework/ Licensed under the Creative Commons Attribution Sharealike 4.0 License https://
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